Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 672 articles:
HTML format
Text format



Single Articles


    September 2017
  1. NAGTZAAM IF, Peeters VPM, Vreeburg M, Wagner A, et al
    Novel CLDN1 mutation in ichthyosis-hypotrichosis-sclerosing-cholangitis syndrome without signs of liver disease.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15996.
    PubMed     Text format     Abstract available


  2. HIETIKKO M, Hervonen K, Salmi T, Ilus T, et al
    Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of dermatitis herpetiformis patients after a long-term gluten-free diet.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15995.
    PubMed     Text format     Abstract available


  3. HOTZ A, Fagerberg C, Vahlquist A, Bygum A, et al
    Identification of Mutations in SDR9C7 in 6 Families with Autosomal Recessive Congenital Ichthyosis.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15994.
    PubMed     Text format     Abstract available


  4. MAJEED-ARISS R, McPhee M, Bundy C, Griffiths CEM, et al
    Developing a protocol to identify and prioritise research questions for psoriasis: A James Lind Alliance Priority Setting Partnership.
    Br J Dermatol. 2017 Sep 14. doi: 10.1111/bjd.15992.
    PubMed     Text format     Abstract available


  5. CHEE SN, Novakovic L, Fassihi H, Garibaldinos T, et al
    Chronic actinic dermatitis: successful treatment with PUVA photochemotherapy.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15969.
    PubMed     Text format     Abstract available


  6. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma: reply from authors.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15972.
    PubMed     Text format     Abstract available


  7. LEWIS DJ, Kim YH, Duvic M
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15970.
    PubMed     Text format     Abstract available


  8. EGEBERG A, Nast A
    The value and pitfalls of biologics registries for psoriasis.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15971.
    PubMed     Text format     Abstract available


  9. WOLNER ZJ, Bajaj S, Flores E, Carrera C, et al
    Variation in dermoscopic features of basal cell carcinoma as a function of anatomic location and pigmentation status.
    Br J Dermatol. 2017 Sep 8. doi: 10.1111/bjd.15964.
    PubMed     Text format     Abstract available


  10. KESSELS JPHM, Kreukels H, Nelemans PJ, Roozeboom MH, et al
    Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus two stage topical methylaminolevulinic acid: results of a randomized controlled trial.
    Br J Dermatol. 2017 Sep 8. doi: 10.1111/bjd.15967.
    PubMed     Text format     Abstract available


  11. SATTLER EC, Ertl-Wagner B, Pellegrini C, Peris K, et al
    Cutaneous melanoma in Birt-Hogg-Dube syndrome - part of the clinical spectrum?
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15937.
    PubMed     Text format     Abstract available


  12. KRASUSKA M, Millings A, Lavda AC, Thompson AR, et al
    Compassion focussed self-help for skin conditions in individuals with insecure attachment: A pilot evaluation of the acceptability and potential effectiveness.
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15934.
    PubMed     Text format     Abstract available


  13. WEIDINGER S, Baurecht H, Schmitt J
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal.
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15827.
    PubMed     Text format     Abstract available


  14. GUALENI B, Coulman SA, Shah D, Eng PF, et al
    Minimally-invasive and targeted therapeutic cell delivery to the skin using microneedle devices.
    Br J Dermatol. 2017 Sep 2. doi: 10.1111/bjd.15923.
    PubMed     Text format     Abstract available


  15. DRUCKER AM, Eyerich K, de Bruin-Weller MS, Thyssen JP, et al
    Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.
    Br J Dermatol. 2017 Sep 2. doi: 10.1111/bjd.15928.
    PubMed     Text format     Abstract available


    August 2017
  16. CHARMAN C
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment.
    Br J Dermatol. 2017 Aug 31. doi: 10.1111/bjd.15848.
    PubMed     Text format    


  17. SANDERS MGH, Pardo LM, Franco OH, Ginger RS, et al
    Prevalence and determinants of seborrheic dermatitis in a middle aged and elderly population: the Rotterdam Study.
    Br J Dermatol. 2017 Aug 30. doi: 10.1111/bjd.15908.
    PubMed     Text format     Abstract available


  18. TSIANAKAS A, Luger TA, Radin A
    Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial.
    Br J Dermatol. 2017 Aug 27. doi: 10.1111/bjd.15905.
    PubMed     Text format     Abstract available


  19. SCHMITT J, Haufe E, Trautmann F, Schulze HJ, et al
    Is UV-exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181.
    Br J Dermatol. 2017 Aug 27. doi: 10.1111/bjd.15906.
    PubMed     Text format     Abstract available


  20. AREVALO-BERMUDEX M, Pita-Fernandez S, Paradela S, Fonseca Capdevila E, et al
    Cutaneous lupus erythematosus. Quality of life and related factors in a cohort of 260 patients of A Coruna, Spain.
    Br J Dermatol. 2017 Aug 20. doi: 10.1111/bjd.15902.
    PubMed     Text format     Abstract available


  21. LIN YK, See LC, Huang YH, Chi CC, et al
    Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double-blind, dosage-controlled trial.
    Br J Dermatol. 2017 Aug 17. doi: 10.1111/bjd.15894.
    PubMed     Text format     Abstract available


  22. KIM HJ, Langenhan JL, Robinson Es ES, Privette E, et al
    Effect of Long-term Treatment with TNFalpha Inhibitors on Single-dose UV-induced Changes in Human Skin.
    Br J Dermatol. 2017 Aug 17. doi: 10.1111/bjd.15897.
    PubMed     Text format     Abstract available


  23. MATTII M, Lovaszi M, Garzorz N, Atenhan A, et al
    Sebocytes contribute to skin inflammation by promoting the differentiation of Th17 cells.
    Br J Dermatol. 2017 Aug 11. doi: 10.1111/bjd.15879.
    PubMed     Text format     Abstract available


  24. STEWART CL, Cornejo CM, Wanat KA, Sander I, et al
    The Immune Reconstitution of the Skin Following Sex Mismatched Allogeneic Hematopoietic Stem Cell Transplant: A prospective case series utilizing fluorescent in situ hybridization and immunohistochemistry.
    Br J Dermatol. 2017 Aug 10. doi: 10.1111/bjd.15878.
    PubMed     Text format     Abstract available


  25. ETTINGER M, Schreml J, Wirsching K, Berneburg M, et al
    Skin signs of primary immunodeficiencies - how to find the genes to check.
    Br J Dermatol. 2017 Aug 9. doi: 10.1111/bjd.15870.
    PubMed     Text format     Abstract available


  26. MOSSNER R, Wilsmann-Theis D, Oji V, Gkogkolou P, et al
    The genetic basis for most patients with pustular skin disease remains elusive.
    Br J Dermatol. 2017 Aug 5. doi: 10.1111/bjd.15867.
    PubMed     Text format     Abstract available


  27. YOULDEN DR, Baade PD, Aitken JF, Green AC, et al
    Prognostic importance of a second invasive primary melanoma according to tumor stage.
    Br J Dermatol. 2017 Aug 3. doi: 10.1111/bjd.15863.
    PubMed     Text format     Abstract available


  28. NAST A, Dilleen M, Liyanage W, Aikman L, et al
    Time, PASI and DLQI of psoriasis patients who "drop out" of clinical trials on etanercept due to "lack of efficacy" - a pooled analysis from ten clinical trials.
    Br J Dermatol. 2017 Aug 3. doi: 10.1111/bjd.15864.
    PubMed     Text format     Abstract available


  29. HAMBLY R, Kelly A, Gilhooley E, Nic Dhonncha E, et al
    Medication adherence among psoriasis patients on traditional systemic and biologic treatment.
    Br J Dermatol. 2017 Aug 1. doi: 10.1111/bjd.15856.
    PubMed     Text format     Abstract available


  30. GUIDA M, Ruggieri E, Fucci L, Ressa M, et al
    Image Gallery: A case of cutaneous giant angiosarcoma treated successfully with electrochemotherapy.
    Br J Dermatol. 2017;177:e27.
    PubMed     Text format    


  31. BERK-KRAUSS J, Stein JA
    The role of access to care in acral lentiginous melanoma survival.
    Br J Dermatol. 2017;177:341-342.
    PubMed     Text format    


  32. DE BRITO M, Gazzani P, Amel-Kashipaz R, Vydianath B, et al
    Image Gallery: Secondary cutaneous involvement of the ear with systemic small lymphocytic lymphoma: a rare manifestation.
    Br J Dermatol. 2017;177:e26.
    PubMed     Text format    


  33. FOULKES AC, Brown SJ
    Genetic prediction of treatment response in psoriasis is still a work in progress.
    Br J Dermatol. 2017;177:344-345.
    PubMed     Text format    


  34. ROSEN CF
    Fatigue and psoriasis.
    Br J Dermatol. 2017;177:346-347.
    PubMed     Text format    


  35. UITTO J, Youssefian L, Vahidnezhad H
    Expanding mutation landscape and phenotypic spectrum of autosomal recessive congenital ichthyosis.
    Br J Dermatol. 2017;177:342-343.
    PubMed     Text format    


  36. KRAMER ON, Jerdan K, Worobec SM
    Image Gallery: Haemorrhagic shock due to a cutaneous pyogenic granuloma.
    Br J Dermatol. 2017;177:e24.
    PubMed     Text format    


  37. HARRIS V, Smith SD
    Lifting the biofilm lid on the antibacterial and antibiofilm effects of sodium hypochlorite against Staphylococcus aureus in atopic dermatitis.
    Br J Dermatol. 2017;177:347-348.
    PubMed     Text format    


  38. NIJSTEN T, Leigh IM
    Keratinocyte skin cancers in the spotlight.
    Br J Dermatol. 2017;177:334-335.
    PubMed     Text format    


  39. HILL D, Lovat P
    Cover Image: Invasion of a cutaneous melanoma tumour.
    Br J Dermatol. 2017;177:599.
    PubMed     Text format    


  40. ABBOTT P
    Patient-centred health care for people with chronic skin conditions.
    Br J Dermatol. 2017;177:329-330.
    PubMed     Text format    


  41. KIRBY B
    Drug survival of methotrexate in psoriasis.
    Br J Dermatol. 2017;177:345-346.
    PubMed     Text format    


  42. COSTA FECHINE CO, Anzai A, Valente NY, Romiti R, et al
    Image Gallery: Folliculitis keloidalis on white-skinned scalp vertex.
    Br J Dermatol. 2017;177:e25.
    PubMed     Text format    


  43. SAMUEL RJ, Reynolds NJ
    Ustekinumab for severe atopic dermatitis: an important negative study.
    Br J Dermatol. 2017;177:339-341.
    PubMed     Text format    


    July 2017
  44. BASRA MKA, Salek MS, Fenech D, Finlay AY, et al
    Conceptualisation, development and validation of T-QoL(c) (Teenagers' Quality of Life): a patient-focused measure to assess quality of life of adolescents with skin diseases.
    Br J Dermatol. 2017 Jul 31. doi: 10.1111/bjd.15853.
    PubMed     Text format     Abstract available


  45. ADLER NR, Kelly JW, Haydon A, McLean CA, et al
    Clinicopathological characteristics and prognosis of patients with multiple primary melanomas.
    Br J Dermatol. 2017 Jul 28. doi: 10.1111/bjd.15855.
    PubMed     Text format     Abstract available


  46. PAPP K, Bachelez H, Costanzo A, Foley P, et al
    Clinical Similarity of the Biosimilar ABP 501 Compared With Adalimumab After Single Transition: Long-Term Results From a Randomised, Double-Blind, 52-Week, Phase 3 Study in Moderate-to-Severe Plaque Psoriasis Patients.
    Br J Dermatol. 2017 Jul 28. doi: 10.1111/bjd.15857.
    PubMed     Text format     Abstract available


  47. YEN H, Dhana A, Okhovat JP, Qureshi A, et al
    Alcohol intake and risk of nonmelanoma skin cancer: a systematic review and dose-response meta-analysis.
    Br J Dermatol. 2017 Jul 26. doi: 10.1111/bjd.15647.
    PubMed     Text format     Abstract available


  48. DIAS-SANTAGATA D, Selim MA, Su Y, Peng Y, et al
    KIT Mutations and CD117 Overexpression Are Markers of Better Progression-Free Survival in Vulvar Melanomas.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15836.
    PubMed     Text format     Abstract available


  49. ORTEGA LOAYZA AG, Nugent WH, Lucero OM, Washington SL, et al
    Dysregulation of inflammatory gene expression in lesional and non-lesional skin of patients with pyoderma gangrenosum.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15837.
    PubMed     Text format     Abstract available


  50. ALONSO N, Canueto J, Ciria S, Bueno E, et al
    Novel clinical and molecular findings in Spanish patients with Nevoid Basal Cell Carcinoma Syndrome.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15835.
    PubMed     Text format     Abstract available


  51. BUSARD CIM, Nolte JYC, Pasch MC, Spuls PI, et al
    Reporting of outcomes in randomised controlled trials on nail psoriasis; a Systematic Review.
    Br J Dermatol. 2017 Jul 19. doi: 10.1111/bjd.15831.
    PubMed     Text format     Abstract available


  52. PELEVA E, Exton LS, Kelley K, Mason KJ, et al
    Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.
    Br J Dermatol. 2017 Jul 19. doi: 10.1111/bjd.15830.
    PubMed     Text format     Abstract available


  53. ROPKE M, Bulai Livideanu C, Kaldate R, Snel A, et al
    Changes in IL-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study.
    Br J Dermatol. 2017 Jul 19. doi: 10.1111/bjd.15814.
    PubMed     Text format     Abstract available


  54. TERAMOTO Y, Keim U, Gesierich A, Schuler G, et al
    Acral lentiginous melanoma - a skin cancer with unfavourable prognostic features. A study of the German Central Malignant Melanoma Registry (CMMR) in 2050 patients.
    Br J Dermatol. 2017 Jul 14. doi: 10.1111/bjd.15803.
    PubMed     Text format     Abstract available


  55. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat - How shall we treat? A review of the literature.
    Br J Dermatol. 2017 Jul 13. doi: 10.1111/bjd.15801.
    PubMed     Text format     Abstract available


  56. MENG W, Veluchamy A, Hebert HL, Campbell A, et al
    A genome-wide association study suggested that the mitogen-activated protein kinase 14 gene (MAPK14) is associated with diabetic foot ulcer.
    Br J Dermatol. 2017 Jul 3. doi: 10.1111/bjd.15787.
    PubMed     Text format     Abstract available


  57. GIBBS DC, Ward SV, Orlow I, Cadby G, et al
    Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas.
    Br J Dermatol. 2017 Jul 1. doi: 10.1111/bjd.15784.
    PubMed     Text format     Abstract available


  58. ESSERS BAB, Arits AH, Hendriks MR, Mosterd K, et al
    Patient preferences for the attributes of a non-invasive treatment for superficial Basal cell carcinoma: a discrete choice experiment.
    Br J Dermatol. 2017 Jul 1. doi: 10.1111/bjd.15782.
    PubMed     Text format     Abstract available


  59. PAINSI C, Lange-Asschenfeldt B
    Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection.
    Br J Dermatol. 2017;177:e1.
    PubMed     Text format    


  60. ISHII N
    Prognostic factors of patients with linear IgA bullous dermatosis.
    Br J Dermatol. 2017;177:16-17.
    PubMed     Text format    


  61. JACOB SE
    Percutaneous absorption risks in atopic dermatitis.
    Br J Dermatol. 2017;177:11-12.
    PubMed     Text format    


  62. PINK AE, Smith CH
    Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists.
    Br J Dermatol. 2017;177:7-8.
    PubMed     Text format    


  63. MCCOURT C
    Antimalarials in cutaneous lupus erythematous subtypes.
    Br J Dermatol. 2017;177:14-15.
    PubMed     Text format    


  64. STOFF BK
    A new potential option for topical treatment of basal cell carcinoma?
    Br J Dermatol. 2017;177:12-13.
    PubMed     Text format    


  65. EGEBERG A, Nast A
    A critical eye on registry data in psoriasis.
    Br J Dermatol. 2017;177:245-246.
    PubMed     Text format    


    June 2017
  66. SMEDINGA H, Verkouteren JAC, Steyerberg EW, Hofman A, et al
    Occurrence of metachronous basal cell carcinomas: a prognostic model.
    Br J Dermatol. 2017 Jun 30. doi: 10.1111/bjd.15771.
    PubMed     Text format     Abstract available


  67. HOGENDOORN GK, Bruggink SC, de Koning MNC, Eekhof JAH, et al
    Morphological characteristics and HPV genotype predict the treatment response in cutaneous warts.
    Br J Dermatol. 2017 Jun 24. doi: 10.1111/bjd.15758.
    PubMed     Text format     Abstract available


  68. VAN VUGT LJ, van den Reek JMPA, Coenen MJH, de Jong EMGJ, et al
    A systematic review of pharmacogenetic studies on the response to biologics in psoriasis patients.
    Br J Dermatol. 2017 Jun 24. doi: 10.1111/bjd.15753.
    PubMed     Text format     Abstract available


  69. COHEN AD, Wu JJ, Puig L, Chimenti S, et al
    Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology Clinical Practice.
    Br J Dermatol. 2017 Jun 24. doi: 10.1111/bjd.15756.
    PubMed     Text format     Abstract available


  70. RICCERI F, Pescitelli L, Lazzeri L, Prignano F, et al
    Clinical experience with infliximab biosimilar in psoriasis.
    Br J Dermatol. 2017 Jun 24. doi: 10.1111/bjd.15755.
    PubMed     Text format     Abstract available


  71. HJALTE F, Steen Carlsson K, Schmitt-Egenolf M
    Sustained PASI, DLQI and EQ-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.
    Br J Dermatol. 2017 Jun 23. doi: 10.1111/bjd.15757.
    PubMed     Text format     Abstract available


  72. LOWE AJ, Su JC, Allen KJ, Abramson MJ, et al
    A randomised trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitisation: The PEBBLES Pilot Study.
    Br J Dermatol. 2017 Jun 22. doi: 10.1111/bjd.15747.
    PubMed     Text format     Abstract available


  73. LANGLEY RG, Tsai TF, Flavin S, Song M, et al
    Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: Results of the randomized, double-blind, Phase 3 NAVIGATE trial.
    Br J Dermatol. 2017 Jun 21. doi: 10.1111/bjd.15750.
    PubMed     Text format     Abstract available


  74. SMIT AK, Keogh LA, Newson AJ, Butow PN, et al
    Does personalised melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?
    Br J Dermatol. 2017 Jun 19. doi: 10.1111/bjd.15744.
    PubMed     Text format     Abstract available


  75. AGUSTI J, Bella-Navarro R, Garcia-Garcia AB, Bueno E, et al
    Familial seborrhoeic keratosis associated with multiple "pure reticulated acanthomas" and infundibulocystic basal cell carcinomas.
    Br J Dermatol. 2017 Jun 18. doi: 10.1111/bjd.15736.
    PubMed     Text format     Abstract available


  76. ADLER NR, Graudins LV, Aung AK
    The importance of risk communication and documentation for patients with cutaneous adverse drug reactions.
    Br J Dermatol. 2017 Jun 18. doi: 10.1111/bjd.15737.
    PubMed     Text format     Abstract available


  77. OLTEANU C, Dodiuk-Gad R, Hashimoto R, Shear N, et al
    Letter to the Editor concerning the article "Long term complications of Stevens-Johnson syndrome/Toxic epidermal necrolysis: The spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multi-disciplinary follow up.
    Br J Dermatol. 2017 Jun 18. doi: 10.1111/bjd.15734.
    PubMed     Text format     Abstract available


  78. DRUCKER AM, Qureshi AA, Dummer TJB, Parker L, et al
    Atopic dermatitis and risk of hypertension, type-2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project.
    Br J Dermatol. 2017 Jun 15. doi: 10.1111/bjd.15727.
    PubMed     Text format     Abstract available


  79. ALWAN W, Lynch M, McFadden J, White IR, et al
    Patch testing in psoriasis patients: results of a 30-year retrospective study.
    Br J Dermatol. 2017 Jun 15. doi: 10.1111/bjd.15730.
    PubMed     Text format     Abstract available


  80. KIM SK, Barker CA
    Outcomes of radiation therapy for advanced T3/T4 non-melanoma cutaneous squamous cell and basal cell carcinoma.
    Br J Dermatol. 2017 Jun 15. doi: 10.1111/bjd.15728.
    PubMed     Text format     Abstract available


  81. BLAUVELT A, Ferris LK, Yamauchi PS, Qureshi A, et al
    Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a Phase 3b, randomized, double-blinded, active-controlled, multicenter study (PSTELLAR).
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15722.
    PubMed     Text format     Abstract available


  82. PAPP KA, Bachelez H, Blauvelt A, Winthrop KL, et al
    Infections from 7 Clinical Trials of Ixekizumab, an Anti-Interleukin-17A Monoclonal Antibody, in Patients with Moderate-to-Severe Psoriasis.
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15723.
    PubMed     Text format     Abstract available


  83. EGU DT, Walter E, Spindler V, Waschke J, et al
    Inhibition of p38MAPK signaling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis.
    Br J Dermatol. 2017 Jun 10. doi: 10.1111/bjd.15721.
    PubMed     Text format     Abstract available


  84. LEE WJ, Kim YJ, Lee YJ, Won CH, et al
    VEGF protein expression is associated with a poor prognosis in cutaneous extranodal NK/T-cell lymphoma patients.
    Br J Dermatol. 2017 Jun 9. doi: 10.1111/bjd.15720.
    PubMed     Text format     Abstract available


  85. HOFFMANN JHO, Knoop C, Enk AH, Hadaschik EN, et al
    Long persistence of TNF-alpha antagonist induced autoantibodies under subsequent treatment with Ustekinumab but no adverse effects: a case study of 14 psoriasis patients.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15701.
    PubMed     Text format     Abstract available


  86. BONNEKOH H, Scheffel J, Maurer M, Krause K, et al
    The use of skin biomarker profiles to distinguish Schnitzler's syndrome from chronic spontaneous urticaria: results of a pilot study.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15705.
    PubMed     Text format     Abstract available


  87. STICHERLING M, Mrowietz U, Augustin M, Thaci D, et al
    Secukinumab is Superior to Fumaric Acid Esters in Treating Subjects with Moderate to Severe Plaque Psoriasis who are Naive to Systemic Treatments: Results from the Randomized Controlled PRIME Trial.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15707.
    PubMed     Text format     Abstract available


  88. DI FUSCO D, Laudisi F, Dinallo V, Monteleone I, et al
    Smad7 positively regulates keratinocyte proliferation in psoriasis.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15703.
    PubMed     Text format     Abstract available


  89. BISSONNETTE R, Luger T, Thaci D, Toth D, et al
    Secukinumab Sustains Good Efficacy and Favourable Safety in Moderate to Severe Psoriasis up to 3 Years of Treatment: Results from A Double-Blind Extension Study.
    Br J Dermatol. 2017 Jun 5. doi: 10.1111/bjd.15706.
    PubMed     Text format     Abstract available


  90. KIESELOVA K, Santiago F, Henrique M, Cunha F, et al
    Image Gallery: Cutaneous lesions in the external auditory canal causing hearing loss.
    Br J Dermatol. 2017;176:e119.
    PubMed     Text format    


  91. BALATO A, Caiazzo G
    Mesenchymal stem cells participate to inflammatory skin process of atopic dermatitis.
    Br J Dermatol. 2017;176:1437-1438.
    PubMed     Text format    


  92. DRUCKER AM
    Treating moderate-to-severe atopic dermatitis: what do dermatologists do with limited evidence?
    Br J Dermatol. 2017;176:1441-1442.
    PubMed     Text format    


  93. PAMPALAKIS G, Sotiropoulou G
    Insights into the regulation of proteolytic pathways in skin differentiation.
    Br J Dermatol. 2017;176:1433-1434.
    PubMed     Text format    


  94. CERIO R, Moir G
    Palliative electrochemotherapy treatment of metastatic malignant melanoma.
    Br J Dermatol. 2017;176:1427.
    PubMed     Text format    


  95. JONES G
    Methotrexate increases the risk of melanoma: or does it?
    Br J Dermatol. 2017;176:1429-1430.
    PubMed     Text format    


  96. TRAUPE H
    Psoriasis and the interleukin-10 family: evidence for a protective genetic effect, but not an easy target as a drug.
    Br J Dermatol. 2017;176:1438-1439.
    PubMed     Text format    


  97. AGNER T
    Biomarkers in contact dermatitis.
    Br J Dermatol. 2017;176:1434-1435.
    PubMed     Text format    


  98. MOSCARELLA E, Ametrano O, Diplomatico M, De Chiara C, et al
    Image Gallery: Kaposiform haemangioendothelioma.
    Br J Dermatol. 2017;176:e124.
    PubMed     Text format    


    May 2017
  99. CONDORELLI AG, Fortugno P, Cianfarani F, Proto V, et al
    Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin EGF-like (LE) motif 2 of the beta3 short arm.
    Br J Dermatol. 2017 May 31. doi: 10.1111/bjd.15690.
    PubMed     Text format     Abstract available


  100. GONZALEZ N, Patel P, Han G
    A Dissimilar Biosimilar?: Lichenoid Drug Eruption Induced by an Infliximab Biosimilar.
    Br J Dermatol. 2017 May 30. doi: 10.1111/bjd.15686.
    PubMed     Text format     Abstract available


  101. GRIFFITHS CEM, van der Walt JM, Ashcroft DM, Flohr C, et al
    The global state of psoriasis disease epidemiology: a workshop report.
    Br J Dermatol. 2017 May 28. doi: 10.1111/bjd.15610.
    PubMed     Text format     Abstract available


  102. RIBERO S, Carrera C, Tell-Marti G, Pastorino C, et al
    Amelanotic melanoma in oculocutaneous albinism: a genetic, dermoscopic and reflectance confocal microscopy study.
    Br J Dermatol. 2017 May 27. doi: 10.1111/bjd.15687.
    PubMed     Text format     Abstract available


  103. EGEBERG A, Griffiths CEM, Mallbris L, Gislason GH, et al
    The association between psoriasis and coeliac disease.
    Br J Dermatol. 2017 May 27. doi: 10.1111/bjd.15684.
    PubMed     Text format     Abstract available


  104. DOU J, Zhang L, Xie X, Ye L, et al
    Integrative analyses reveal biological pathways and key genes in psoriasis.
    Br J Dermatol. 2017 May 25. doi: 10.1111/bjd.15682.
    PubMed     Text format     Abstract available


  105. REICH K, Pinter A, Lacour JP, Ferrandiz C, et al
    Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a Phase 3 study.
    Br J Dermatol. 2017 May 19. doi: 10.1111/bjd.15666.
    PubMed     Text format     Abstract available


  106. SMITH CH, Jabbar-Lopez ZK, Yiu ZZ, Bale T, et al
    British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.
    Br J Dermatol. 2017 May 17. doi: 10.1111/bjd.15665.
    PubMed     Text format     Abstract available


  107. RODRIGUEZ-JIMENEZ P, Chicharro P, Godoy A, Llamas-Velasco M, et al
    No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab.
    Br J Dermatol. 2017 May 16. doi: 10.1111/bjd.15654.
    PubMed     Text format     Abstract available


  108. CASSIUS C, Moguelet P, Monfort JB, Fessi H, et al
    Calciphylaxis in hemodialysed patients: Diagnostic value of calcifications in cutaneous biopsy.
    Br J Dermatol. 2017 May 12. doi: 10.1111/bjd.15655.
    PubMed     Text format     Abstract available


  109. GISONDI P, Bianchi L, Conti A, Dapavo P, et al
    Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis. Data from the Psobiosimilars registry.
    Br J Dermatol. 2017 May 12. doi: 10.1111/bjd.15659.
    PubMed     Text format     Abstract available


  110. BLAUVELT A, Reich K, Warren RB, Szepietowski JC, et al
    Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis.
    Br J Dermatol. 2017 May 12. doi: 10.1111/bjd.15656.
    PubMed     Text format     Abstract available


  111. IP SCI, Cottle DL, Jones LK, Weir JM, et al
    BJD Research Letter: A profile of lipid dysregulation in Harlequin Ichthyosis.
    Br J Dermatol. 2017 May 10. doi: 10.1111/bjd.15642.
    PubMed     Text format     Abstract available


  112. CHOPRA R, Vakharia PP, Sacotte R, Patel N, et al
    Severity strata for EASI, mEASI, oSCORAD, SCORAD, ADSI and BSA in adolescents and adults with atopic dermatitis.
    Br J Dermatol. 2017 May 9. doi: 10.1111/bjd.15641.
    PubMed     Text format     Abstract available


  113. TAPIA JC, Chavez K, Malaga G, Bravo F, et al
    Treatment satisfaction and need for shared decision-making in patients with psoriasis from Peru.
    Br J Dermatol. 2017 May 9. doi: 10.1111/bjd.15639.
    PubMed     Text format     Abstract available


  114. TASANI M, Ancliff P, Glover M
    Sirolimus therapy for children with problematic Kaposiform haemangioendothelioma and tufted angioma.
    Br J Dermatol. 2017 May 9. doi: 10.1111/bjd.15640.
    PubMed     Text format     Abstract available


  115. KOLIOS AGA, Biedermann L, Weber A, Navarini AA, et al
    Paradoxical ulcerative colitis during Adalimumab treatment of psoriasis resolved by switch to Ustekinumab.
    Br J Dermatol. 2017 May 6. doi: 10.1111/bjd.15631.
    PubMed     Text format     Abstract available


  116. BAUVIN O, L Schmutz J, Busato T, Cribier B, et al
    A foot tumor as late cutaneous Lyme borreliosis: a new entity?
    Br J Dermatol. 2017 May 6. doi: 10.1111/bjd.15633.
    PubMed     Text format     Abstract available


  117. SIMONSEN AB, Johansen JD, Deleuran M, Mortz CG, et al
    Contact allergy in children with atopic dermatitis: a systematic review.
    Br J Dermatol. 2017 May 3. doi: 10.1111/bjd.15628.
    PubMed     Text format     Abstract available


  118. YANG CW, Tsai TF
    Image Gallery: Resolution of lichen striatus in a patient with coexisting chronic plaque psoriasis and vitiligo during secukinumab treatment.
    Br J Dermatol. 2017;176:e96.
    PubMed     Text format    


  119. GRIEWANK KG
    Epidermal growth factor receptor gaining impact in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2017;176:1126-1127.
    PubMed     Text format    


  120. MAGIN P
    Aggression and its associations in patients with skin disease.
    Br J Dermatol. 2017;176:1118-1119.
    PubMed     Text format    


  121. KAUR P
    Hair-follicle dermal papilla and sheath fibroblasts provide a supportive microenvironment for human skin regeneration.
    Br J Dermatol. 2017;176:1123-1124.
    PubMed     Text format    


  122. PUIG L, Putrik P
    Psoriasis: inequality or individualized care?
    Br J Dermatol. 2017;176:1111-1113.
    PubMed     Text format    


  123. ZHUANG K, Tang J, Ran Y
    Image Gallery: Acute primary cutaneous nocardiosis due to Nocardia brasiliensis.
    Br J Dermatol. 2017;176:e97.
    PubMed     Text format    


  124. JIMENEZ F
    Incorporating hair follicle cells in artificial skin.
    Br J Dermatol. 2017;176:1124-1125.
    PubMed     Text format    


  125. APFELBACHER CJ, Ofenloch RF
    The impact of skin conditions on generic health-related quality of life.
    Br J Dermatol. 2017;176:1109-1110.
    PubMed     Text format    


  126. RYAN C
    Identification of pharmacogenetic markers of treatment response to biologic therapies in psoriasis - is there a benefit?
    Br J Dermatol. 2017;176:1127-1128.
    PubMed     Text format    


  127. SWETTER SM
    Challenges of treating melanoma in situ, lentigo maligna type: is pathological clearance the gold standard?
    Br J Dermatol. 2017;176:1115-1116.
    PubMed     Text format    


  128. ELLIS RA
    T-type calcium channels as potential biomarkers in melanoma.
    Br J Dermatol. 2017;176:1122.
    PubMed     Text format    


  129. WANG L, Long H, Wen H, Liu Z, et al
    Image Gallery: Generalized mucosal and cutaneous papillomatosis, a unique sign of malignant acanthosis nigricans.
    Br J Dermatol. 2017;176:e99.
    PubMed     Text format    


  130. KRENGEL S, Reyes-Mugica M
    Melanoma risk in congenital melanocytic naevi.
    Br J Dermatol. 2017;176:1114.
    PubMed     Text format    


  131. RAMOT Y
    Psoriasis and osteoporosis: the debate continues.
    Br J Dermatol. 2017;176:1117-1118.
    PubMed     Text format    


  132. FARRAR MD
    Topical photodynamic therapy: the preferred choice for cutaneous field-cancerization?
    Br J Dermatol. 2017;176:1116-1117.
    PubMed     Text format    


    April 2017
  133. DIXON A, Steinman H, Anderson S, Nirenberg A, et al
    Routine usage of sentinel node biopsy in melanoma management must cease: reply from authors.
    Br J Dermatol. 2017 Apr 29. doi: 10.1111/bjd.15626.
    PubMed     Text format     Abstract available


  134. AMIN M, No DJ, Wu JJ
    Reply to 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials'.
    Br J Dermatol. 2017 Apr 29. doi: 10.1111/bjd.15620.
    PubMed     Text format     Abstract available


  135. WEI L, Allain DC, Bernhardt MN, Gillespie JL, et al
    Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs.
    Br J Dermatol. 2017 Apr 29. doi: 10.1111/bjd.15618.
    PubMed     Text format     Abstract available


  136. SALEH DB
    RE: Routine usage of sentinel node biopsy in melanoma management must cease.
    Br J Dermatol. 2017 Apr 29. doi: 10.1111/bjd.15619.
    PubMed     Text format     Abstract available


  137. POLAT A, Dinulescu M, Fraitag S, Nimubona S, et al
    Skin manifestations among GATA2-deficient patients.
    Br J Dermatol. 2017 Apr 25. doi: 10.1111/bjd.15548.
    PubMed     Text format     Abstract available


  138. ASGARI MM, Shen L, Sokil MM, Yeh I, et al
    Prognostics factors and survival in acral lentiginous melanoma.
    Br J Dermatol. 2017 Apr 22. doi: 10.1111/bjd.15600.
    PubMed     Text format     Abstract available


  139. TIAO J, Feng R, Berger EM, Brandsema JF, et al
    Evaluation of the Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and the Cutaneous Assessment Tool Binary Method (CAT-BM) in Juvenile Dermatomyositis Among Pediatric Dermatologists, Rheumatologists, and Neurologis
    Br J Dermatol. 2017 Apr 19. doi: 10.1111/bjd.15596.
    PubMed     Text format     Abstract available


  140. SANLORENZO M, Vujic I, De Giorgi V, Tomasini C, et al
    Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation.
    Br J Dermatol. 2017 Apr 19. doi: 10.1111/bjd.15594.
    PubMed     Text format     Abstract available


  141. ROCHA L, Menzies SW, Lo S, Avramidis M, et al
    Analysis of an electrical impedance spectroscopy system in short-term digital dermoscopy imaging of melanocytic lesions.
    Br J Dermatol. 2017 Apr 19. doi: 10.1111/bjd.15595.
    PubMed     Text format     Abstract available


  142. CHEOK S, Yee F, Ma JYS, Leow R, et al
    Prevalence and Descriptive Epidemiology of Atopic Dermatitis and Its Impact on Quality of Life in Singapore.
    Br J Dermatol. 2017 Apr 17. doi: 10.1111/bjd.15587.
    PubMed     Text format     Abstract available


  143. CHEN S, Kong X, Wei X, Sun Y, et al
    Targeted next-generation sequencing identifies 9 novel FLG variants in Chinese Han patients with ichthyosis vulgaris.
    Br J Dermatol. 2017 Apr 13. doi: 10.1111/bjd.15588.
    PubMed     Text format     Abstract available


  144. STAROKADOMSKYY P, Sifuentes-Dominguez L, Gemelli T, Zinn AR, et al
    Evolution of the skin manifestations of X-linked Pigmentary Reticulate Disorder.
    Br J Dermatol. 2017 Apr 13. doi: 10.1111/bjd.15586.
    PubMed     Text format     Abstract available


  145. ARASE N, Tanimura K, Jin H, Yamaoka T, et al
    Novel autoantibody against the beta2-glycoprotein I/HLA-DR complex in patients with refractory cutaneous ulcers.
    Br J Dermatol. 2017 Apr 12. doi: 10.1111/bjd.15571.
    PubMed     Text format     Abstract available


  146. BOYDEN LM, Craiglow BG, Hu RH, Zhou J, et al
    Phenotypic Spectrum of Autosomal Recessive Congenital Ichthyosis Due to PNPLA1 Mutation.
    Br J Dermatol. 2017 Apr 12. doi: 10.1111/bjd.15570.
    PubMed     Text format     Abstract available


  147. NELSON PA, Kane K, Pearce CJ, Bundy C, et al
    'New to me' - changing patient understanding of psoriasis and identifying mechanisms of change: The Pso Well(R) patient materials mixed methods feasibility study.
    Br J Dermatol. 2017 Apr 12. doi: 10.1111/bjd.15574.
    PubMed     Text format     Abstract available


  148. HUANG C, Liu L, You Z, Zhao Y, et al
    Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis.
    Br J Dermatol. 2017 Apr 12. doi: 10.1111/bjd.15576.
    PubMed     Text format     Abstract available


  149. KADOUCH DJ, Elshot YS, Zupan-Kajcovski B, van Haersma de With AS, et al
    One-stop-shop with confocal microscopy imaging versus standard care for surgical treatment of basal cell carcinoma: an open label, non-inferiority, randomized controlled multicenter trial.
    Br J Dermatol. 2017 Apr 9. doi: 10.1111/bjd.15559.
    PubMed     Text format     Abstract available


  150. GUALANO MR, Osella-Abate S, Scaioli G, Marra E, et al
    Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis.
    Br J Dermatol. 2017 Apr 7. doi: 10.1111/bjd.15552.
    PubMed     Text format     Abstract available


  151. DAVISON NJ, Warren RB, Mason KJ, McElhone K, et al
    Identification of factors that may influence the selection of first-line biologic therapy for people with psoriasis: a prospective, multi-centre cohort study.
    Br J Dermatol. 2017 Apr 7. doi: 10.1111/bjd.15551.
    PubMed     Text format     Abstract available


  152. JACQUEMIN C, Rambert J, Guillet S, Thiolat D, et al
    HSP70 potentiates interferon-alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis.
    Br J Dermatol. 2017 Apr 5. doi: 10.1111/bjd.15550.
    PubMed     Text format     Abstract available


  153. BROOKS J, Ersser SJ, Cowdell F, Gardiner E, et al
    A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia.
    Br J Dermatol. 2017 Apr 4. doi: 10.1111/bjd.15543.
    PubMed     Text format     Abstract available


  154. KEMPF W
    Cutaneous lymphomas in childhood and adolescence: much needed new data.
    Br J Dermatol. 2017;176:857-858.
    PubMed     Text format    


  155. HUNTER HJA
    Can positron emission tomography (PET) unravel the link between adipose tissue, vascular inflammation and cardiovascular risk in patients with psoriasis?
    Br J Dermatol. 2017;176:864-865.
    PubMed     Text format    


  156. CHANSKY PB, Mittal L, Werth VP
    Dermatological evaluation in patients with skin of colour: the effect of erythema on outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:853-854.
    PubMed     Text format    


  157. NALDI L
    Finding a HOME for outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:852-853.
    PubMed     Text format    


  158. ORMEROD AD
    Five-year efficacy of biologics for psoriasis in the real world of daily practice.
    Br J Dermatol. 2017;176:856-857.
    PubMed     Text format    


  159. BERTOLINI M, Rossi A, Paus R
    Cover Image: Are melanocyte-associated peptides the elusive autoantigens in alopecia areata?
    Br J Dermatol. 2017;176:1106.
    PubMed     Text format    


  160. NIJSTEN T, Wakkee M
    The four Ws of skin cancer surveillance in patients with melanoma: Why? Who? When? Where?
    Br J Dermatol. 2017;176:839-841.
    PubMed     Text format    


  161. HAUSSER I
    Ichthyoses: new insights unravel defects in skin barrier function resulting in diverse clinical and morphological phenotypes.
    Br J Dermatol. 2017;176:863-864.
    PubMed     Text format    


  162. WATTS CG
    The challenge of skin surveillance: observe or biopsy?
    Br J Dermatol. 2017;176:851-852.
    PubMed     Text format    


    March 2017
  163. KARIM N, Murtaza G, Naeem M
    Whole Exome Sequencing Identified a Novel Frameshift Mutation in SDR9C7 underlying Autosomal Recessive Congenital Ichthyosis in a Pakistani Family.
    Br J Dermatol. 2017 Mar 31. doi: 10.1111/bjd.15535.
    PubMed     Text format     Abstract available


  164. DLOVA NC, Chateau A, Khoza N, Skenjane A, et al
    Prevalence of skin diseases treated at public referral hospitals in KwaZulu-Natal, South Africa.
    Br J Dermatol. 2017 Mar 31. doi: 10.1111/bjd.15534.
    PubMed     Text format     Abstract available


  165. DYRING-ANDERSEN B, Velte Honore T, Madelung A, Bzorek M, et al
    IL-17A and IL-22 producing neutrophils in psoriatic skin.
    Br J Dermatol. 2017 Mar 31. doi: 10.1111/bjd.15533.
    PubMed     Text format     Abstract available


  166. KOIKE Y, Okubo M, Kiyohara T, Fukuchi R, et al
    Granulocyte and monocyte apheresis can control juvenile generalised pustular psoriasis with mutation of the IL36RN gene.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15509.
    PubMed     Text format     Abstract available


  167. DE RISI-PUGLIESE T, Servy A, Decousser JW, Nebbad B, et al
    Skin biopsy PCR for rapid microbiological diagnosis in patients with purpura fulminans.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15503.
    PubMed     Text format     Abstract available


  168. CHANG J, Tran DC, Zhu GA, Li R, et al
    Initial in vitro functional characterization of serum exosomal microRNAs from patients with metastatic basal cell carcinoma.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15508.
    PubMed     Text format     Abstract available


  169. LOTT JP, Wang Q, Titus LJ, Onega T, et al
    Temporal Trends in Healthcare Utilization following Primary Melanoma Diagnosis among Medicare Beneficiaries.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15530.
    PubMed     Text format     Abstract available


  170. POLUBOTHU S, Scott RH, Vabres P, Kinsler VA, et al
    Atypical dermal melanocytosis: diagnostic clue in constitutional mismatch repair deficiency syndrome.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15532.
    PubMed     Text format     Abstract available


  171. OVEJERO-BENITO MC, Cabaleiro T, Sanz-Garcia A, Llamas-Velasco M, et al
    Epigenetic biomarkers associated with anti-TNF drugs response in moderate-to- severe psoriasis.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15504.
    PubMed     Text format     Abstract available


  172. KARIMKHANI C, Green AC, Nijsten T, Weinstock MA, et al
    The Global Burden of Melanoma: Results from Global Burden of Disease Study 2015.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15510.
    PubMed     Text format     Abstract available


  173. ISKANDAR IY, Ashcroft DM, Warren RB, Lunt M, et al
    Comparative effectiveness of biologic therapies on improvements in quality of life in patients with psoriasis.
    Br J Dermatol. 2017 Mar 30. doi: 10.1111/bjd.15531.
    PubMed     Text format     Abstract available


  174. KOGUCHI-YOSHIOKA H, Okiyama N, Iwamoto K, Matsumura Y, et al
    Intravenous immunoglobulin contributes to control anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis with palmar violaceous macules/papules.
    Br J Dermatol. 2017 Mar 27. doi: 10.1111/bjd.15499.
    PubMed     Text format     Abstract available


  175. AL-JEFRI K, Newbury-Birch D, Muirhead CR, Gilvarry E, et al
    High prevalence of alcohol use disorders in patients with inflammatory skin diseases.
    Br J Dermatol. 2017 Mar 27. doi: 10.1111/bjd.15497.
    PubMed     Text format     Abstract available


  176. SAEKI H, Kabashima K, Tokura Y, Murata Y, et al
    Efficacy and Safety of Ustekinumab in Japanese Patients with Severe Atopic Dermatitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study.
    Br J Dermatol. 2017 Mar 24. doi: 10.1111/bjd.15493.
    PubMed     Text format     Abstract available


  177. ANDOH T, Shimizu T
    Increase in sensory sensitivity around, but not in the central part of, the hyperkeratotic papule in lichen amyloidosis.
    Br J Dermatol. 2017 Mar 23. doi: 10.1111/bjd.15488.
    PubMed     Text format     Abstract available


  178. ANDERSEN YM, Egeberg A, Gislason GH, Skov L, et al
    Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis.
    Br J Dermatol. 2017 Mar 23. doi: 10.1111/bjd.15489.
    PubMed     Text format     Abstract available


  179. HENRY AL, Kyle SD, Chisholm A, Griffiths CE, et al
    A cross-sectional survey of the nature and correlates of sleep disturbance in people with psoriasis.
    Br J Dermatol. 2017 Mar 17. doi: 10.1111/bjd.15469.
    PubMed     Text format     Abstract available


  180. CHAN BC, Stefanato CM, Moonim MT, Morris SL, et al
    Diffuse large B-Cell lymphoma developing in erythrodermic cutaneous T-cell lymphoma: a case series.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15460.
    PubMed     Text format     Abstract available


  181. TEO Y, Walsh S, Creamer D
    Cutaneous Adverse Drug Reactions Referrals to a Liaison Dermatology Service.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15461.
    PubMed     Text format     Abstract available


  182. BLAUVELT A, Griffiths CE, Lebwohl M, Mrowietz U, et al
    Reaching complete or near complete resolution of psoriasis: benefit and risk considerations.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15463.
    PubMed     Text format     Abstract available


  183. INZELBERG R, Friedman E, Azizi E
    Cutaneous squamous cell carcinoma and the PARK2 gene.
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15465.
    PubMed     Text format     Abstract available


  184. REICH K, Zschocke I, Bachelez H, de Jong EM, et al
    A Topical Treatment Optimisation Programme (TTOP) improves clinical outcome to calcipotriol/betamethasone gel in psoriasis: Results of the 64-week, multinational, randomized, phase IV study in 1790 patients (PSO-TOP).
    Br J Dermatol. 2017 Mar 16. doi: 10.1111/bjd.15466.
    PubMed     Text format     Abstract available


  185. ATWAN A, Piguet V, Finlay AY, Francis NA, et al
    Dermatology Life Quality Index (DLQI) as a psoriasis referral triage tool.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15446.
    PubMed     Text format     Abstract available


  186. LICCIARDELLO M, T Giura M, Rozzo G, Marra E, et al
    Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15447.
    PubMed     Text format     Abstract available


  187. NABIL R, Bergman W, Kukutsch NA
    Poor agreement between a mobile phone application for the analysis of skin lesions and the clinical diagnosis of the dermatologist, a pilot study.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15443.
    PubMed     Text format     Abstract available


  188. TAKEICHI T, Kobayashi A, Ogawa E, Okuno Y, et al
    Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15442.
    PubMed     Text format     Abstract available


  189. RICHTIG G, Hoeller C, Kashofer K, Aigelsreiter A, et al
    Beyond the BRAFV600E hotspot - Biology and clinical implications of rare BRAF gene mutations in melanoma patients.
    Br J Dermatol. 2017 Mar 9. doi: 10.1111/bjd.15436.
    PubMed     Text format     Abstract available


  190. WOLK K, Wenzel J, Tsaousi A, Witte-Handel E, et al
    Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa / hidradenitis suppurativa.
    Br J Dermatol. 2017 Mar 3. doi: 10.1111/bjd.15424.
    PubMed     Text format     Abstract available


  191. ADLER NR, Aung AK, Ergen EN, Trubiano J, et al
    Recent advances in the understanding of severe cutaneous adverse reactions.
    Br J Dermatol. 2017 Mar 3. doi: 10.1111/bjd.15423.
    PubMed     Text format     Abstract available


  192. REICH A
    Interleukin-17 blockade in generalized pustular psoriasis - new hope for severely ill patients.
    Br J Dermatol. 2017;176:572-573.
    PubMed     Text format    


  193. GRIFFITHS CE
    Systems medicine and psoriasis.
    Br J Dermatol. 2017;176:560-562.
    PubMed     Text format    


  194. CUST AE, Murrell DF
    Increasing prevalence but not incidence of psoriasis in the U.K.
    Br J Dermatol. 2017;176:568-569.
    PubMed     Text format    


  195. TRABANELLI S
    Indoleamine 2,3-dioxygenase in psoriasis: a defective mechanism.
    Br J Dermatol. 2017;176:570-572.
    PubMed     Text format    


  196. GISONDI P
    Could maternal stress increase the risk of developing psoriasis in the offspring?
    Br J Dermatol. 2017;176:569-570.
    PubMed     Text format    


  197. YIU ZZ
    Disease-specific treatment registries for research: psoriasis as an exemplar.
    Br J Dermatol. 2017;176:794-796.
    PubMed     Text format    


  198. YIU ZZ
    Psoriasis and increased drug utilization: a true burden of psoriasis or potential surveillance bias of comorbidities?
    Br J Dermatol. 2017;176:566-567.
    PubMed     Text format    


  199. YAN J
    Identifying biomarkers in human psoriasis: revealed by a systems metabolomics approach.
    Br J Dermatol. 2017;176:555-557.
    PubMed     Text format    


  200. ZHENG J
    Absolute Psoriasis Area and Severity Index: an additional evaluation for clinical practice.
    Br J Dermatol. 2017;176:576.
    PubMed     Text format    


  201. KIVELEVITCH D, Michel P, Menter A
    Quality of life instruments in psoriasis clinical trials.
    Br J Dermatol. 2017;176:563.
    PubMed     Text format    


  202. BURDEN AD
    Etanercept or infliximab for psoriasis? An independent randomized clinical trial.
    Br J Dermatol. 2017;176:565.
    PubMed     Text format    


  203. COATES LC
    Patient education and screening for psoriatic arthritis is key in the care of patients with psoriasis, whichever method is chosen.
    Br J Dermatol. 2017;176:574-575.
    PubMed     Text format    


    February 2017
  204. LI S, Villarreal M, Stewart S, Choi J, et al
    Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 28. doi: 10.1111/bjd.15409.
    PubMed     Text format     Abstract available


  205. ERIKSSON S, van der Plas MJ, Morgelin M, Sonesson A, et al
    Antibacterial and anti-biofilm effects of sodium hypochlorite against Staphylococcus aureus isolates derived from patients with atopic dermatitis.
    Br J Dermatol. 2017 Feb 26. doi: 10.1111/bjd.15410.
    PubMed     Text format     Abstract available


  206. CHANG J, Bilker WB, Hoffstad O, Margolis DJ, et al
    Cross-Sectional Comparisons of Patient-Reported Disease Control, Disease Severity, and Symptom Frequency in Children with Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 24. doi: 10.1111/bjd.15403.
    PubMed     Text format     Abstract available


  207. DICK A, Tantcheva-Poor I, Oji V, Giehl KA, et al
    Diminished Protein-Bound omega-Hydroxylated Ceramides In The Skin Of Ichthyosis Patients With 12r-Lox Or Elox-3 Deficiency.
    Br J Dermatol. 2017 Feb 24. doi: 10.1111/bjd.15406.
    PubMed     Text format     Abstract available


  208. CORR M, Roulston G, King N, Dornan T, et al
    Living with 'melanoma'...for a day: a phenomenological analysis of medical students' simulated experiences.
    Br J Dermatol. 2017 Feb 23. doi: 10.1111/bjd.15402.
    PubMed     Text format     Abstract available


  209. TSAI S, Scott JF, Keller JJ, Gerstenblith MR, et al
    Cutaneous malignancies identified on an inpatient Dermatology consult service.
    Br J Dermatol. 2017 Feb 23. doi: 10.1111/bjd.15401.
    PubMed     Text format     Abstract available


  210. PRIETO-BARRIOS M, Velasco-Tamariz V, Tous-Romero F, Burillo-Martinez S, et al
    Linear Immunoglobulin A dermatosis mimicking Toxic Epidermal Necrolysis: a case report of etanercept treatment.
    Br J Dermatol. 2017 Feb 21. doi: 10.1111/bjd.15400.
    PubMed     Text format     Abstract available


  211. VERKOUTEREN JA, Ramdas KH, Wakkee M, Nijsten T, et al
    Epidemiology of basal cell carcinoma: scholarly review.
    Br J Dermatol. 2017 Feb 20. doi: 10.1111/bjd.15321.
    PubMed     Text format     Abstract available


  212. DYBBOE R, Bandier J, Skov L, Engstrand L, et al
    The Role of the Skin Microbiome in Atopic Dermatitis: A Systematic Review.
    Br J Dermatol. 2017 Feb 16. doi: 10.1111/bjd.15390.
    PubMed     Text format     Abstract available


  213. GREEN AC, Olsen CM
    Cutaneous squamous cell carcinoma: an epidemiological review.
    Br J Dermatol. 2017 Feb 16. doi: 10.1111/bjd.15324.
    PubMed     Text format     Abstract available


  214. QIN Z, Balimunkwe RM, Quan T
    Age-related reduction of dermal fibroblast size up-regulates multiple matrix metalloproteinases as observed in aged human skin in vivo.
    Br J Dermatol. 2017 Feb 14. doi: 10.1111/bjd.15379.
    PubMed     Text format     Abstract available


  215. SANTONJA C, Santos-Briz A, Palmedo G, Kutzner H, et al
    Detection of human parvovirus B19 DNA in 22% of 1,815 cutaneous biopsies of a wide variety of dermatologic conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance.
    Br J Dermatol. 2017 Feb 14. doi: 10.1111/bjd.15382.
    PubMed     Text format     Abstract available


  216. BAGEL J, Tyring S, Rice KC, Collier DH, et al
    Open-label study of etanercept treatment in patients with moderate to severe plaque psoriasis who lost a satisfactory response to adalimumab.
    Br J Dermatol. 2017 Feb 14. doi: 10.1111/bjd.15381.
    PubMed     Text format     Abstract available


  217. GOMEZ-GARCIA F, Ruano J, Aguilar-Luque M, Gay-Mimbrera J, et al
    Systematic reviews and meta-analyses on psoriasis: role of funding sources, conflict of interest, and bibliometric indices as predictors of methodological quality.
    Br J Dermatol. 2017 Feb 13. doi: 10.1111/bjd.15380.
    PubMed     Text format     Abstract available


  218. VAZQUEZ-OSORIO I, Chmel N, Rodriguez-Diaz E, Gonzalvo-Rodriguez P, et al
    A case of mosaicism in ectodermal dysplasia - skin fragility syndrome.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15374.
    PubMed     Text format     Abstract available


  219. SKOIE IM, Dalen I 1st, Ternowitz T, Jonsson G, et al
    Fatigue in psoriasis - a controlled study.
    Br J Dermatol. 2017 Feb 9. doi: 10.1111/bjd.15375.
    PubMed     Text format     Abstract available


  220. NG CY, Huang YH, Chu CF, Wu TC, et al
    Risks for Staphylococcus aureus Colonization in Psoriasis Patients: A Systematic Review and Meta-Analysis.
    Br J Dermatol. 2017 Feb 3. doi: 10.1111/bjd.15366.
    PubMed     Text format     Abstract available


  221. GALIMOVA E, Khusnutdinova E, Ratsep R, Traks T, et al
    Interleukin-10 family cytokines pathway: genetic variants and psoriasis.
    Br J Dermatol. 2017 Feb 2. doi: 10.1111/bjd.15363.
    PubMed     Text format     Abstract available


  222. LEE HY, Walsh SA, Creamer D
    Long term complications of Stevens-Johnson syndrome / Toxic epidermal necrolysis: The spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multi-disciplinary follow up.
    Br J Dermatol. 2017 Feb 1. doi: 10.1111/bjd.15360.
    PubMed     Text format     Abstract available


  223. BREMBILLA NC, Stalder R, Senra L, Bohencke WH, et al
    IL-17A localizes in the exocytic compartment of mast cells in psoriatic skin.
    Br J Dermatol. 2017 Feb 1. doi: 10.1111/bjd.15358.
    PubMed     Text format     Abstract available


  224. KING L
    A criteria-validated sun-exposure questionnaire to evaluate skin cancer prevention campaigns.
    Br J Dermatol. 2017;176:298-299.
    PubMed     Text format    


  225. KURTZMAN DJ, Vleugels RA
    Expanding the use of the Cutaneous Dermatomyositis Area and Severity Index (CDASI) to nondermatologists.
    Br J Dermatol. 2017;176:296-297.
    PubMed     Text format    


  226. JOHNSTON GA, Exton LS, Mohd Mustapa MF, Slack JA, et al
    British Association of Dermatologists' guidelines for the management of contact dermatitis 2017.
    Br J Dermatol. 2017;176:317-329.
    PubMed     Text format    


  227. JORDAN M, Ghoreschi K
    Anti-melanoma differentiation-associated protein 5 autoantibodies as a marker for dermatomyositis-associated interstitial lung disease.
    Br J Dermatol. 2017;176:294-295.
    PubMed     Text format    


  228. CHOI JW, Na SY
    Image Gallery: Myoepithelial carcinoma involving the skin.
    Br J Dermatol. 2017;176:e12.
    PubMed     Text format    


  229. MASHAYEKHI S, Flohr C, Lewis FM
    The treatment of vulval lichen sclerosus in prepubertal girls: a critically appraised topic.
    Br J Dermatol. 2017;176:307-316.
    PubMed     Text format     Abstract available


  230. CHOPRA S, Downs A, Perris R
    Intense pulsed light combined with methyl aminolaevulinate for treating actinic keratoses and photoaged skin of the dorsal hands has considerable advantages. However, is it worth the extra expense?
    Br J Dermatol. 2017;176:290-291.
    PubMed     Text format    


  231. LINDBERG M, Soderquist B
    Atopic dermatitis and gut microbiota.
    Br J Dermatol. 2017;176:297-298.
    PubMed     Text format    


  232. LINOS E, Bhatia S, Chren MM
    More than skin-deep: is basal cell carcinoma a marker for a cancer-prone phenotype?
    Br J Dermatol. 2017;176:305-306.
    PubMed     Text format    


  233. KUHN A, Landmann A, Bonsmann G
    Fumaric acid esters: a new therapeutic option for skin manifestations in lupus erythematosus?
    Br J Dermatol. 2017;176:301-302.
    PubMed     Text format    


  234. PARK J, Yun SK, Kim HU
    Image Gallery: Heel-line band of infancy: postinflammatory skin change associated with tight socks.
    Br J Dermatol. 2017;176:e15.
    PubMed     Text format    


  235. DRUCKER AM
    Taking steps to improve the assessment and management of rosacea.
    Br J Dermatol. 2017;176:283-284.
    PubMed     Text format    


  236. WEISSHAAR E
    Outcome measures in patients with chronic pruritus: moving forward but still a long way to go.
    Br J Dermatol. 2017;176:291-292.
    PubMed     Text format    


  237. FOLSTER-HOLST R
    Severe systemic juvenile xanthogranuloma is an indication for systemic therapy.
    Br J Dermatol. 2017;176:302-304.
    PubMed     Text format    


  238. FLETCHER J, Haniffa M
    Mechanisms of immune evasion in extramammary Paget disease.
    Br J Dermatol. 2017;176:293-294.
    PubMed     Text format    


  239. HASHIMOTO T
    Induced autoimmune bullous diseases.
    Br J Dermatol. 2017;176:304-305.
    PubMed     Text format    


  240. EGEBERG A
    Evidence-based management of rosacea.
    Br J Dermatol. 2017;176:300-301.
    PubMed     Text format    


  241. INGRAM JR, Burton T
    NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Br J Dermatol. 2017;176:281-282.
    PubMed     Text format    


  242. SAKAI A, Shimomura Y, Ansai O, Saito Y, et al
    Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180.
    Br J Dermatol. 2017;176:541-543.
    PubMed     Text format    


    January 2017
  243. WOLNER ZJ, Marghoob AA, Pulitzer MP, Postow MA, et al
    A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15354.
    PubMed     Text format     Abstract available


  244. LANGTON AK, Graham HK, McConnell JC, Sherratt MJ, et al
    Organisation of the dermal matrix impacts the biomechanical properties of skin.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15353.
    PubMed     Text format     Abstract available


  245. VAN SANTEN S, van Doorn R, Neelis KJ, Daniels LA, et al
    Recommendations for treatment in Folliculotropic Mycosis Fungoides: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2017 Jan 28. doi: 10.1111/bjd.15355.
    PubMed     Text format     Abstract available


  246. CHOI CW, Kim BR, Seo E, Youn SW, et al
    The objective Psoriasis Area Severity Index: A randomised controlled pilot study comparing the effectiveness of cyclosporine and methotrexate using an objective PASI (oPASI).
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15350.
    PubMed     Text format     Abstract available


  247. WU JH, Cohen DN, Rady PL, Tyring SK, et al
    BRAF inhibitor-associated cutaneous squamous cell carcinoma: new mechanistic insight, emerging evidence for a viral involvement, and perspectives on clinical management.
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15348.
    PubMed     Text format     Abstract available


  248. VANHAECKE C, Deilhes F, Chanal J, Regnier-Rosencher E, et al
    BRAFV600 inhibitor discontinuation after complete response in advanced melanoma. A retrospective analysis of 16 patients.
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15345.
    PubMed     Text format     Abstract available


  249. KOGAME T, Nomura T, Kataoka T, Hirata M, et al
    Possible inducible skin-associated lymphoid tissues (iSALT)-like structures with CXCL13+ fibroblast-like cells in secondary syphilis.
    Br J Dermatol. 2017 Jan 27. doi: 10.1111/bjd.15349.
    PubMed     Text format     Abstract available


  250. KUNTE C, Letule V, Gehl J, Dahlstroem K, et al
    Electrochemotherapy in the treatment of metastatic malignant melanoma: A prospective cohort study by InspECT.
    Br J Dermatol. 2017 Jan 24. doi: 10.1111/bjd.15340.
    PubMed     Text format     Abstract available


  251. HAGFORSEN E, Lampinen M, Paivandy A, Westrom S, et al
    Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions.
    Br J Dermatol. 2017 Jan 24. doi: 10.1111/bjd.15336.
    PubMed     Text format     Abstract available


  252. MINAGAWA A, Omodaka T, Koga H, Yokokawa Y, et al
    Nail apparatus melanoma thickness is associated with side and age.
    Br J Dermatol. 2017 Jan 24. doi: 10.1111/bjd.15318.
    PubMed     Text format     Abstract available


  253. CHASSET F, Bouaziz JD, Costedoat-Chalumeau N, Frances C, et al
    Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15312.
    PubMed     Text format     Abstract available


  254. ZHOU H, Shi HJ, Yang J, Chen WG, et al
    Efficacy and relapse-suppression of severe plaque psoriasis by oxymatrine: Results from a single blinded randomized controlled clinical trial.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15316.
    PubMed     Text format     Abstract available


  255. VAN DEN REEK JM, Menting SP, Janssen WW, Dhaliwal R, et al
    PIIINP measurements for the detection of liver fibrosis in methotrexate treated psoriasis patients: Daily practice use and clinical implications.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15313.
    PubMed     Text format     Abstract available


  256. TAKEICHI T, Nomura T, Takama H, Kono M, et al
    Deficient stratum corneum intercellular lipid in a Japanese patient with lamellar ichthyosis by a homozygous deletion mutation in SDR9C7.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15315.
    PubMed     Text format     Abstract available


  257. WAALBOER-SPUIJ R, Hollestein LM, van de Poll-Franse LV, Nijsten TE, et al
    Histological diagnosis of basal cell carcinoma is not associated with life expectancy in elderly Dutch people; a population-based cohort study.
    Br J Dermatol. 2017 Jan 23. doi: 10.1111/bjd.15310.
    PubMed     Text format     Abstract available


  258. ZIMMER AD, Kim GJ, Hotz A, Bourrat E, et al
    16 novel mutations in PNPLA1 in patients with autosomal recessive congenital ichthyosis reveal the importance of an extended patatin domain in PNPLA1 that is essential for proper human skin barrier function.
    Br J Dermatol. 2017 Jan 17. doi: 10.1111/bjd.15308.
    PubMed     Text format     Abstract available


  259. SIMPSON JK, Wilson M, Ahmed AA, Mizara A, et al
    An exploratory study to investigate health-seeking behaviour in patients with psoriasis using framework analysis.
    Br J Dermatol. 2017 Jan 13. doi: 10.1111/bjd.15307.
    PubMed     Text format     Abstract available


  260. OTERO M, van den Reek J, Seyger M, Van Der Kerkhof P, et al
    Determinants for drug survival of Methotrexate in patients with psoriasis, split for different reasons of discontinuation - Results of the prospective MTX-CAPTURE.
    Br J Dermatol. 2017 Jan 12. doi: 10.1111/bjd.15305.
    PubMed     Text format     Abstract available


  261. KINSLER VA, O'Hare P, Bulstrode N, Calonje JE, et al
    Melanoma in congenital melanocytic naevi.
    Br J Dermatol. 2017 Jan 12. doi: 10.1111/bjd.15301.
    PubMed     Text format     Abstract available


  262. SU HH, Wu W, Guo Y, Chen HD, et al
    Pediatric Erdheim-Chester disease with aggressive skin manifestations.
    Br J Dermatol. 2017 Jan 12. doi: 10.1111/bjd.15306.
    PubMed     Text format     Abstract available


  263. RAZMI T M, Mahajan R, Agrawal P
    Image Gallery: Cutaneous botryomycosis at an unusual site in an immunocompetent patient.
    Br J Dermatol. 2017;176:e3.
    PubMed     Text format    


  264. BARZILAI A, Cohen AD
    Expanding the skin and histopathology manifestations of autoinflammatory diseases.
    Br J Dermatol. 2017;176:18-19.
    PubMed     Text format    


  265. TSURUTA D
    Intercellular IgA dermatosis.
    Br J Dermatol. 2017;176:13-14.
    PubMed     Text format    


  266. BRATTSAND M
    Missing factors in human skin equivalent models?
    Br J Dermatol. 2017;176:11-12.
    PubMed     Text format    


  267. MARIA-ENGLER SS
    Assessing the effects of advanced glycation end products in the skin.
    Br J Dermatol. 2017;176:12-13.
    PubMed     Text format    


  268. CHONG BF
    Patient-reported outcomes in patients with cutaneous lupus.
    Br J Dermatol. 2017;176:7.
    PubMed     Text format    


  269. FOERSTER J
    Rare diseases and costly treatments: the role of IL-1beta in pustular psoriasis.
    Br J Dermatol. 2017;176:17-18.
    PubMed     Text format    


  270. HAS C
    Mosaicism in the skin: lumping or splitting?
    Br J Dermatol. 2017;176:15-16.
    PubMed     Text format    


    December 2016
  271. KHOURY LR, Skov L, Moller T
    Facing the dilemma of patient-centred psoriasis care: a qualitative study identifying patient needs in dermatological outpatient clinics.
    Br J Dermatol. 2016 Dec 29. doi: 10.1111/bjd.15292.
    PubMed     Text format     Abstract available


  272. BALIEVA F, Kupfer J, Lien L, Gieler U, et al
    The Burden of Common Skin Diseases Assessed with the EQ5D: a European Multi-centre Study in 13 Countries.
    Br J Dermatol. 2016 Dec 29. doi: 10.1111/bjd.15280.
    PubMed     Text format     Abstract available


  273. HAMBLY R, Mansoor N, Quinlan C, Shah Z, et al
    Topical Photodynamic Therapy for Primary Bowen's Disease and Basal Cell Carcinoma - Optimising Patient Selection.
    Br J Dermatol. 2016 Dec 27. doi: 10.1111/bjd.15281.
    PubMed     Text format     Abstract available


  274. ZHAO CY, Hao EY, Oh DD, Daniel BS, et al
    A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate to dark skin patients.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15271.
    PubMed     Text format     Abstract available


  275. OH CC, Hofbauer GF, Serra AL, Harwood CA, et al
    Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: A cohort study.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15269.
    PubMed     Text format     Abstract available


  276. NEITTAANMAKI N, Salmivuori M, Polonen I, Jeskanen L, et al
    Hyperspectral imaging in detecting dermal invasion in lentigo maligna melanoma.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15267.
    PubMed     Text format     Abstract available


  277. SCHAEFER C, Mamolo C, Cappelleri JC, Daniel S, et al
    Treatment Patterns and Outcomes among Adults Admitted to Hospital in the United Kingdom (UK) due to Plaque or Erythrodermic Psoriasis.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15270.
    PubMed     Text format     Abstract available


  278. USHER-SMITH JA, Kassianos AP, Emery JD, Abel GA, et al
    Identifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic survey.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15181.
    PubMed     Text format     Abstract available


  279. BENSEFA-COLAS L, Stocks SJ, McNamee R, Faye S, et al
    Effectiveness of the European Chromium VI Directive for cement implementation on occupational allergic contact dermatitis occurrence: Assessment in France and UK.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15261.
    PubMed     Text format     Abstract available


  280. TOBIN AM, Sadlier M, Collins P, Rogers S, et al
    Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15258.
    PubMed     Text format     Abstract available


  281. NIC DHONNCHA E, Clowry J, Dunphy M, Buckley C, et al
    Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15262.
    PubMed     Text format     Abstract available


  282. HERMS F, Franck N, Kramkimel N, Fichel F, et al
    Neutrophilic eccrine hidradenitis in 2 patients treated with BRAF inhibitors: a new cutaneous adverse event.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15259.
    PubMed     Text format     Abstract available


  283. GOTTLIEB J, Ingen-Housz-Oro S, Alexandre M, Grootenboer-Mignot S, et al
    Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case-series of 72 adults.
    Br J Dermatol. 2016 Dec 20. doi: 10.1111/bjd.15244.
    PubMed     Text format     Abstract available


  284. SAMPOGNA F, Puig L, Spuls P, Girolomoni G, et al
    Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study.
    Br J Dermatol. 2016 Dec 20. doi: 10.1111/bjd.15243.
    PubMed     Text format     Abstract available


  285. HELANDER A, Bradley M, Hasselblad A, Norlen L, et al
    Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.
    Br J Dermatol. 2016 Dec 14. doi: 10.1111/bjd.15174.
    PubMed     Text format     Abstract available


  286. NALDI L, Cazzaniga S, di Mercurio M, Grossi E, et al
    Inequalities in access to biological treatments for psoriasis: Results from the Italian Psocare Registry.
    Br J Dermatol. 2016 Dec 14. doi: 10.1111/bjd.15234.
    PubMed     Text format     Abstract available


  287. CANUETO J, Cardenoso-Alvarez E, Garcia-Hernandez JL, Galindo-Villardon P, et al
    miR-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2016 Dec 11. doi: 10.1111/bjd.15236.
    PubMed     Text format     Abstract available


  288. OHATA C, Ishii N, Koga H, Nakama T, et al
    A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone in direct immunofluorescence.
    Br J Dermatol. 2016 Dec 11. doi: 10.1111/bjd.15232.
    PubMed     Text format     Abstract available


  289. CHANG Y, Anolik R, Cabral H, Bhawan J, et al
    Frequency of Squamous Cell Carcinoma In Situ and Squamous Cell Carcinoma in Re-Excisions of Biopsy-Proven Cutaneous Squamous Cell Carcinoma In Situ.
    Br J Dermatol. 2016 Dec 11. doi: 10.1111/bjd.15230.
    PubMed     Text format     Abstract available


  290. MARTINEZ-MERA C, Camarero-Mulas C, Sanz-Sanchez T, Dauden E, et al
    Combination therapy of infliximab and cyclosporin in the treatment of recalcitrant psoriasis. A case series.
    Br J Dermatol. 2016 Dec 11. doi: 10.1111/bjd.15229.
    PubMed     Text format     Abstract available


  291. VAN DER VOORT EA, Wakkee M, Veldt-Kok P, Darwish Murad S, et al
    Enhanced liver fibrosis test (ELF) in psoriasis, psoriatic arthritis and rheumatoid arthritis patients: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15220.
    PubMed     Text format     Abstract available


  292. LIU X, Chen J, Olsen J, Schlunssen V, et al
    Prenatal exposure to maternal bereavement and offspring psoriasis: a Danish nationwide cohort study.
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15224.
    PubMed     Text format     Abstract available


  293. RICHTIG G, Richtig E, Kashofer K, Koch L, et al
    Testing and clinical implications for non-V600 BRAF mutations in metastatic NRASmt melanoma.
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15222.
    PubMed     Text format     Abstract available


  294. LINOS E, Li WQ, Han J, Li T, et al
    Lifetime UV exposure and Lentigo Maligna Melanoma.
    Br J Dermatol. 2016 Dec 7. doi: 10.1111/bjd.15218.
    PubMed     Text format     Abstract available


  295. SPENDER LC, Inman GJ
    Fatal attractions? Correlations of CXCL12-CXCR4-CXCR7 expression with disease progression in melanoma and Kaposi sarcoma.
    Br J Dermatol. 2016;175:1140-1141.
    PubMed     Text format    


  296. SHIIYA C, Watanabe K, Ota M
    Image Gallery: Lichen amyloidosis on the external auditory canal.
    Br J Dermatol. 2016;175:e149.
    PubMed     Text format    


  297. YELAMOS O, Nehal KS
    Integrating clinical information, dermoscopy and reflectance confocal microscopy to improve the diagnostic accuracy and confidence of amelanotic and lightly pigmented melanomas.
    Br J Dermatol. 2016;175:1147-1148.
    PubMed     Text format    


  298. HAASS NK
    JNK-ERK signalling in melanoma: rewired or entangled?
    Br J Dermatol. 2016;175:1139-1140.
    PubMed     Text format    


  299. NAMIKI T, Tokoro S, Hanafusa T, Yokozeki H, et al
    Image Gallery: Periorbital and temporal dermal melanocytosis of hypohidrotic ectodermal dysplasia.
    Br J Dermatol. 2016;175:e146-e147.
    PubMed     Text format    


  300. ULRICH M
    Optical coherence tomography for diagnosis of basal cell carcinoma: essentials and perspectives.
    Br J Dermatol. 2016;175:1145-1146.
    PubMed     Text format    


  301. DIXON A, Steinman H, Anderson S, Nirenberg A, et al
    Routine usage of sentinel node biopsy in melanoma management must cease.
    Br J Dermatol. 2016;175:1340-1341.
    PubMed     Text format    


  302. SOURA E, Chasapi V, Stratigos AJ
    Programmed cell death protein-1 inhibitors for immunotherapy of advanced nonmelanoma skin cancer: showing early promise.
    Br J Dermatol. 2016;175:1150-1151.
    PubMed     Text format    


  303. YANIK EL
    Skin cancer in the end-stage renal disease population: unique risk factors for patients on dialysis.
    Br J Dermatol. 2016;175:1136-1137.
    PubMed     Text format    


    November 2016
  304. DAMIAN DL, Martin AJ, Scolyer RA, Chen AC, et al
    Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients': reply from the authors.
    Br J Dermatol. 2016 Nov 28. doi: 10.1111/bjd.15204.
    PubMed     Text format     Abstract available


  305. DURAN J, Morgan FC, Karia PS, Schmults CD, et al
    An evaluation of high-stage cutaneous squamous cell carcinoma outcomes by gender.
    Br J Dermatol. 2016 Nov 28. doi: 10.1111/bjd.15208.
    PubMed     Text format     Abstract available


  306. YELAMOS O, Halpern AC, Weinstock MA
    Reply to: A Phase 2 Randomised Controlled Trial of Nicotinamide for Skin Cancer Chemoprevention in Renal Transplant Recipients.
    Br J Dermatol. 2016 Nov 23. doi: 10.1111/bjd.15203.
    PubMed     Text format     Abstract available


  307. DHANA A, Gumedze F, Khumalo N
    Regarding "Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study".
    Br J Dermatol. 2016 Nov 22. doi: 10.1111/bjd.15197.
    PubMed     Text format     Abstract available


  308. SPEIGL L, Janssen N, Weide B, Pawelec G, et al
    Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
    Br J Dermatol. 2016 Nov 21. doi: 10.1111/bjd.15194.
    PubMed     Text format     Abstract available


  309. ROEKEVISCH E, Leeflang MM, Schram ME, Campbell LE, et al
    Atopic dermatitis patients with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
    Br J Dermatol. 2016 Nov 19. doi: 10.1111/bjd.15191.
    PubMed     Text format     Abstract available


  310. HART VA
    Response to ' A functional mechanistic study of the effect of emollients on the structure and function of the skin barrier'.
    Br J Dermatol. 2016 Nov 19. doi: 10.1111/bjd.15184.
    PubMed     Text format     Abstract available


  311. KORKMAZ S, Korkmaz H
    Effect of Alterations in Apoptotic pathway on Development of Metabolic Syndrome in Patients with Psoriasis Vulgaris.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15185.
    PubMed     Text format     Abstract available


  312. WOBSER M, Maurus K, Roth S, Appenzeller S, et al
    MYD88 mutations in a distinct type of cutaneous marginal zone lymphoma with a non-class switched IgM-immunophenotype.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15183.
    PubMed     Text format     Abstract available


  313. MAHER NG, Blumetti TP, Gomes EE, Cheng HM, et al
    Melanoma diagnosis may be a pitfall for optical coherence tomography assessment of equivocal amelanotic or hypomelanotic skin lesions.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15187.
    PubMed     Text format     Abstract available


  314. DESCAMPS V, Claessens YE, Doumenc B
    Skin manifestations in ultra-marathon runners: experience in the Marathon des Sables 2014.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15182.
    PubMed     Text format     Abstract available


  315. POLESIE S, Gillstedt M, Sonnergren HH, Osmancevic A, et al
    Methotrexate Treatment and Risk for Cutaneous Malignant Melanoma - a Retrospective Comparative Registry-based Cohort Study.
    Br J Dermatol. 2016 Nov 10. doi: 10.1111/bjd.15170.
    PubMed     Text format     Abstract available


  316. GONZALEZ-LOPEZ G, Ceballos-Rodriguez RM, Gonzalez-Lopez JJ, Feito Rodriguez M, et al
    Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2016 Nov 8. doi: 10.1111/bjd.15165.
    PubMed     Text format     Abstract available


  317. DAMSKY W, King BA
    STATing the obvious: it's time for new treatments in atopic dermatitis.
    Br J Dermatol. 2016;175:861-862.
    PubMed     Text format    


  318. PUIG L
    Interleukin-17 in skin: psoriasis and yonder.
    Br J Dermatol. 2016;175:859-860.
    PubMed     Text format    


  319. EDWARDS C
    Measurements of structure and function of skin: emollient effects on atopic dermatitis.
    Br J Dermatol. 2016;175:868-869.
    PubMed     Text format    


  320. VASAITIS L
    Metal dust as a possible inducer of immunoglobulin G4-related skin nodules.
    Br J Dermatol. 2016;175:871.
    PubMed     Text format    


  321. BARRETT JH
    Telomere length and melanoma - is there a straightforward relationship?
    Br J Dermatol. 2016;175:865-866.
    PubMed     Text format    


  322. ELLIKER KR, Williams HC
    Detection of skin cancer odours using dogs: a step forward in melanoma detection training and research methodologies.
    Br J Dermatol. 2016;175:851-852.
    PubMed     Text format    


  323. EISEMANN N
    Routine health data in skin cancer screening evaluation.
    Br J Dermatol. 2016;175:862.
    PubMed     Text format    


  324. EGEBERG A
    Fumarates for treatment of psoriasis.
    Br J Dermatol. 2016;175:857.
    PubMed     Text format    


  325. SCHOFIELD JK, Linos E, Callander J
    Management of skin cancer in the frail elderly: time for a rethink?
    Br J Dermatol. 2016;175:855-856.
    PubMed     Text format    


  326. KIRBY B
    Is late-onset psoriasis a distinct subtype of chronic plaque psoriasis?
    Br J Dermatol. 2016;175:869-870.
    PubMed     Text format    


  327. KIMURA Y, Shimada-Omori R, Takahashi T, Tsuchiyama K, et al
    Therapeutic drug monitoring of patients with psoriasis during tumour necrosis factor (TNF)-alpha antagonist treatment using a novel interleukin-8 reporter cell line.
    Br J Dermatol. 2016;175:979-987.
    PubMed     Text format     Abstract available


  328. STROM MA, Fishbein AB, Paller AS, Silverberg JI, et al
    Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.
    Br J Dermatol. 2016;175:920-929.
    PubMed     Text format     Abstract available


  329. TOMIDA E, Kato Y, Ozawa H, Hasegawa H, et al
    Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
    Br J Dermatol. 2016;175:1106-1108.
    PubMed     Text format    


  330. WEILER L, Poulalhon N, Slama A, Guillaud-Bataille M, et al
    Isolated cutaneous leiomyosarcoma revealing a novel germline mutation of the fumarate hydratase gene.
    Br J Dermatol. 2016;175:1104-1106.
    PubMed     Text format    


  331. GYLDENLOVE M, Vilsboll T, Holst JJ, Zachariae C, et al
    Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasis.
    Br J Dermatol. 2016;175:1085-1088.
    PubMed     Text format    


  332. HUNTER HJ, Hinz R, Gerhard A, Talbot PS, et al
    Brain inflammation and psoriasis: a [11 C]-(R)-PK11195 positron emission tomography study.
    Br J Dermatol. 2016;175:1082-1084.
    PubMed     Text format    


    October 2016
  333. GRIFFITHS CE, Thaci D, Gerdes S, Arenberger P, et al
    The EGALITY study: A confirmatory, randomised, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, versus the originator product in patients with moderate to severe chronic plaque-type psor
    Br J Dermatol. 2016 Oct 27. doi: 10.1111/bjd.15152.
    PubMed     Text format     Abstract available


  334. HJULER KF, Gormsen L, Vendelbo MH, Egeberg A, et al
    Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis.
    Br J Dermatol. 2016 Oct 27. doi: 10.1111/bjd.15149.
    PubMed     Text format     Abstract available


  335. KIM JY, Lee EJ, Seo J, Oh SH, et al
    Impact of HMGB1 on melanocytic survival and its involvement in the pathogenesis of vitiligo.
    Br J Dermatol. 2016 Oct 27. doi: 10.1111/bjd.15151.
    PubMed     Text format     Abstract available


  336. HEPBURN L, Hijnen DJ, Sellman BR, Mustelin T, et al
    The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.
    Br J Dermatol. 2016 Oct 25. doi: 10.1111/bjd.15139.
    PubMed     Text format     Abstract available


  337. BATH-HEXTALL F, Nalubega S, Evans C
    The needs and experiences of skin cancer patients: a qualitative systematic review with meta-synthesis.
    Br J Dermatol. 2016 Oct 24. doi: 10.1111/bjd.15148.
    PubMed     Text format     Abstract available


  338. TIAO J, Feng R, Bird S, Choi JK, et al
    The reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) among dermatologists, rheumatologists and neurologists.
    Br J Dermatol. 2016 Oct 19. doi: 10.1111/bjd.15140.
    PubMed     Text format     Abstract available


  339. RICHTIG G, Byrom L, Kupsa R, Schaider H, et al
    Pregnancy as driver for melanoma.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15124.
    PubMed     Text format     Abstract available


  340. LARESE FILON F, Plazzotta S, Rui F, Mauro M, et al
    Ten years incidence of contact dermatitis in a prospective cohort of health care workers in Trieste Hospitals (North East of Italy) 2004-2013.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15118.
    PubMed     Text format     Abstract available


  341. VAN GEEL MJ, Otero ME, de Jong EM, van de Kerkhof PC, et al
    Validation of the Simplified Psoriasis Index (SPI) in Dutch children and adolescents with plaque psoriasis.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15120.
    PubMed     Text format     Abstract available


  342. MODALSLI EH, Asvold BO, Romundstad PR, Langhammer A, et al
    Psoriasis, fracture risk and bone mineral density: The HUNT Study, Norway.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15123.
    PubMed     Text format     Abstract available


  343. MAIQUES O, Macia A, Moreno S, Barcelo C, et al
    Immunohistochemical analysis of T-type calcium channels in acquired melanocytic nevi and melanoma.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15121.
    PubMed     Text format     Abstract available


  344. VAN CRANENBURGH OD, Nijland SB, Lindeboom R, de Korte J, et al
    Patients with lichen sclerosus experience moderate satisfaction with treatment and impairment of quality of life: results of a cross-sectional study.
    Br J Dermatol. 2016 Oct 8. doi: 10.1111/bjd.15125.
    PubMed     Text format     Abstract available


  345. HOORENS I, Brochez L
    Chemoprevention of basal cell carcinoma: reply from authors.
    Br J Dermatol. 2016 Oct 7. doi: 10.1111/bjd.15055.
    PubMed     Text format    


  346. GOON PK, Greenberg DC, Igali L, Levell NJ, et al
    Predicted cases of UK skin SCC and BCC in 2020 and 2025: Horizon planning for NHS Dermatology and Dermatopathology.
    Br J Dermatol. 2016 Oct 7. doi: 10.1111/bjd.15110.
    PubMed     Text format     Abstract available


  347. RUSSO T, Piccolo V, Staibano S, Alfano R, et al
    Image Gallery: Segmental cutaneous leiomyomas in a patient with Reed syndrome.
    Br J Dermatol. 2016;175:e123.
    PubMed     Text format    


  348. SIMONSEN S, Vera Casano A, Gomez Moyano E, Sanz Trelles A, et al
    Image Gallery: Complete remission of aggressive desmoid-type fibromatosis after low-dose methotrexate for 2 weeks in a child with psoriasis.
    Br J Dermatol. 2016;175:e122.
    PubMed     Text format    


  349. LALLAS A, Argenziano G, Ioannides D
    Dermoscopy for basal cell carcinoma subtype prediction.
    Br J Dermatol. 2016;175:674-5.
    PubMed     Text format    


  350. STAMATAS GN
    Neonatal skin barrier.
    Br J Dermatol. 2016;175:670-1.
    PubMed     Text format    



  351. British Skin Foundation, Skin Deep - 20 Years of Research, 20th Anniversary Conference, 13th October 2016, Royal College of Physicians, London, U.K.
    Br J Dermatol. 2016;175 Suppl 2:35-69.
    PubMed     Text format    


  352. O'SHEA SJ, Davies JR, Newton-Bishop JA
    Vitamin D, vitamin A, the primary melanoma transcriptome and survival.
    Br J Dermatol. 2016;175 Suppl 2:30-34.
    PubMed     Text format     Abstract available


  353. JARRETT R, Ogg G
    Lipid-specific T cells and the skin.
    Br J Dermatol. 2016;175 Suppl 2:19-25.
    PubMed     Text format     Abstract available


  354. MARRS T, Flohr C
    The role of skin and gut microbiota in the development of atopic eczema.
    Br J Dermatol. 2016;175 Suppl 2:13-18.
    PubMed     Text format     Abstract available


  355. MCLEAN WH
    Filaggrin failure - from ichthyosis vulgaris to atopic eczema and beyond.
    Br J Dermatol. 2016;175 Suppl 2:4-7.
    PubMed     Text format     Abstract available


  356. GRAHAM-BROWN R
    Felix Natalis, O BSF The British Skin Foundation 20th Anniversary: an introduction.
    Br J Dermatol. 2016;175 Suppl 2:3.
    PubMed     Text format    


    September 2016
  357. ANJUM N, Robson A, Craythorne E, Mallipeddi R, et al
    Follicular Proliferation or Basal Cell Carcinoma? The first prospective UK study of this histological challenge during Mohs Surgery.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15096.
    PubMed     Text format     Abstract available


  358. TODBERG T, Egeberg A, Jensen P, Gislason G, et al
    Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15095.
    PubMed     Text format     Abstract available


  359. PIZZICHETTA MA, Kittler H, Stanganelli I, Ghigliotti G, et al
    Dermoscopic diagnosis of amelanotic/hypomelanotic melanoma.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15093.
    PubMed     Text format     Abstract available


  360. LICHTER J, Bock U, Lotz C, Groeber F, et al
    Functional expression of N-acetyltransferase 1 (NAT1) in differentiated human skin keratinocytes.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15091.
    PubMed     Text format     Abstract available


  361. BURDEN-TEH E, Thomas KS, Rangaraj S, Murphy R, et al
    Interviews with paediatric rheumatologists about psoriasis and psoriatic arthritis in children: How can specialties learn from each other?
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15090.
    PubMed     Text format     Abstract available


  362. HIGGINS CA, Roger M, Hill R, Ali-Khan AS, et al
    Multifaceted role of hair follicle dermal cells in bioengineered skins.
    Br J Dermatol. 2016 Sep 28. doi: 10.1111/bjd.15087.
    PubMed     Text format     Abstract available


  363. ALINIA H, Moradi Tuchayi S, Smith JA, Richardson IM, et al
    Long-term adherence to topical psoriasis treatment can be abysmal: A one-year randomized intervention study using objective electronic adherence monitoring.
    Br J Dermatol. 2016 Sep 24. doi: 10.1111/bjd.15085.
    PubMed     Text format     Abstract available


  364. THORNELOE RJ, Bundy C, Griffiths CE, Ashcroft DM, et al
    Non-adherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis.
    Br J Dermatol. 2016 Sep 24. doi: 10.1111/bjd.15086.
    PubMed     Text format     Abstract available


  365. GRETHER-BECK S, Marini A, Jaenicke T, Stahl W, et al
    Molecular evidence that oral supplementation with lycopene or lutein protects human skin against ultraviolet radiation: Results from a double-blinded, placebo-controlled, cross-over study.
    Br J Dermatol. 2016 Sep 23. doi: 10.1111/bjd.15080.
    PubMed     Text format     Abstract available


  366. CHAN SA, Shah F, Chiganti S, Stevens A, et al
    Primary Cutaneous B-Cell Lymphoma - Systemic spread is rare whilst cutaneous relapses and secondary malignancies are frequent.
    Br J Dermatol. 2016 Sep 19. doi: 10.1111/bjd.15071.
    PubMed     Text format     Abstract available


  367. WEINSTOCK MA, Lott JP, Wang Q, Titus LJ, et al
    Skin Biopsy Utilization and Melanoma Incidence among Medicare Beneficiaries.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15077.
    PubMed     Text format     Abstract available


  368. SHAHBAZ A, Qiang J, Marinas JE, Kim WB, et al
    Efficacies Of Biologic Therapies at week 12 in patients with Plaque Psoriasis in Real World Academic Clinical Practice: A Canadian Multicentre Retrospective Study.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15069.
    PubMed     Text format     Abstract available


  369. HALLING-OVERGAARD AS, Kezic S, Jakasa I, Engebretsen KA, et al
    Skin absorption through atopic dermatitis skin: a systematic review.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15065.
    PubMed     Text format     Abstract available


  370. LO MC, Maraka J, Garioch J, John WG, et al
    Monitoring vitamin D in the melanoma patient - impact of sun avoidance on vitamin D levels of melanoma patients at a tertiary UK referral melanoma service.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15062.
    PubMed     Text format     Abstract available


  371. TAN W, Zakka LR, Gao L, Wang J, et al
    Pathological Alterations Involve the Entire Skin Physiological Milieu in Infantile and Early Childhood Port Wine Stain.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15068.
    PubMed     Text format     Abstract available


  372. BLAUVELT A, Puig L, Chimenti S, Vender R, et al
    Biosimilars for Psoriasis: Clinical Studies to Determine Similarity.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15067.
    PubMed     Text format     Abstract available


  373. ORCIANI M, Campanati A, Caffarini M, Ganzetti G, et al
    Th1 -Th17 and Th2 imbalance in Mesenchymal Stem Cells of adult patients with atopic dermatitis: at the origin of the problem.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15078.
    PubMed     Text format     Abstract available


  374. SHIMODA Y, Sato Y, Hayashida Y, Yamazaki Y, et al
    Lichen amyloidosus as a sweat gland/duct-related disorder: Resolution associated with restoration of sweating disturbance.
    Br J Dermatol. 2016 Sep 15. doi: 10.1111/bjd.15060.
    PubMed     Text format     Abstract available


  375. PARK MK, Li W, Paek SY, Li X, et al
    Consumption of polyunsaturated fatty acids and risk of incident psoriasis and psoriatic arthritis from the Nurses' Health Study II.
    Br J Dermatol. 2016 Sep 15. doi: 10.1111/bjd.15059.
    PubMed     Text format     Abstract available


  376. ALDOORI N, Dobson K, Holden CR, McDonagh AJ, et al
    Statistical inaccuracies over use of facial skin care products and sunscreens in the aetiology of frontal fibrosing alopecia: reply from authors.
    Br J Dermatol. 2016 Sep 13. doi: 10.1111/bjd.15056.
    PubMed     Text format     Abstract available


  377. SEEGOBIN SD, Tziotzios C, Stefanato CM, Bhargava K, et al
    Statistical inaccuracies over use of facial skin care products and sunscreens in the aetiology of frontal fibrosing alopecia.
    Br J Dermatol. 2016 Sep 10. doi: 10.1111/bjd.15054.
    PubMed     Text format     Abstract available


  378. HEERFORDT IM, Wulf HC
    Protoporphyrin IX in the skin measured non-invasively predicts photosensitivity in patients with erythropoietic protoporphyria.
    Br J Dermatol. 2016 Sep 7. doi: 10.1111/bjd.15050.
    PubMed     Text format     Abstract available


  379. SCHUURMAN MS, de Waal AC, Thijs EJ, van Rossum MM, et al
    Risk factors for second primary melanoma among Dutch melanoma patients.
    Br J Dermatol. 2016 Sep 5. doi: 10.1111/bjd.15024.
    PubMed     Text format     Abstract available


  380. MOLLOY O, Foley CC, Lally A, Moriarty B, et al
    Progressive Multifocal Leucoencephalopathy and psoriasis.
    Br J Dermatol. 2016 Sep 2. doi: 10.1111/bjd.15028.
    PubMed     Text format     Abstract available


  381. ISKANDAR IY, Ashcroft DM, Warren RB, Evans I, et al
    Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Br J Dermatol. 2016 Sep 2. doi: 10.1111/bjd.15027.
    PubMed     Text format     Abstract available


  382. BALESTRI R, Rech G, Rossi E, Starace M, et al
    Natural history of isolated nail psoriasis and its role as a risk factor for the development of psoriatic arthritis: a single center cross sectional study.
    Br J Dermatol. 2016 Sep 2. doi: 10.1111/bjd.15026.
    PubMed     Text format     Abstract available


  383. FOX J
    A changing treatment paradigm: the role of palliative care in metastatic melanoma.
    Br J Dermatol. 2016;175:462-3.
    PubMed     Text format    


  384. NATSUGA K
    Stem cell markers of skin appendages in human skin tumours.
    Br J Dermatol. 2016;175:459.
    PubMed     Text format    


  385. SBIDIAN E
    Suicide and psoriasis: no longer an association.
    Br J Dermatol. 2016;175:456-7.
    PubMed     Text format    


  386. HENG M
    Protein kinases and phophodiesterases in psoriasis: time to refocus on biochemistry.
    Br J Dermatol. 2016;175:455-6.
    PubMed     Text format    


  387. SCHMITT-EGENOLF M
    Physical activity and lifestyle improvement in the management of psoriasis.
    Br J Dermatol. 2016;175:452-3.
    PubMed     Text format    


    August 2016
  388. SAUNTE DM, Mrowietz U, Puig L, Zachariae C, et al
    Candida infections in psoriasis and psoriatic arthritis patients treated with IL-17 inhibitors and their practical management.
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15015.
    PubMed     Text format     Abstract available


  389. ZWEEGERS J, Groenewoud JM, van den Reek JM, Otero ME, et al
    Comparison of the one and 5-years effectiveness of adalimumab, etanercept and ustekinumab in psoriasis patients in daily clinical practice: Results from the prospective BioCAPTURE registry.
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15023.
    PubMed     Text format     Abstract available


  390. SPRINGATE DA, Parisi R, Kontopantelis E, Reeves D, et al
    Incidence, prevalence and mortality of patients with psoriasis: a UK population-based cohort study.
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15021.
    PubMed     Text format     Abstract available


  391. DALY ML, Gordon PA, Creamer D
    Cutaneous Features of Dermatomyositis associated with Myositis Specific Antibodies.
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15020.
    PubMed     Text format     Abstract available


  392. VENABLES ZC, Bourke JF, Buckley DA, Campbell F, et al
    Has the epidemic of allergic contact dermatitis due to Methylisothiazolinone reached its peak?
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15016.
    PubMed     Text format     Abstract available


  393. LEE UH, Kim BE, Kim DJ, Cho YG, et al
    Atopic dermatitis is associated with reduced corneodesmosin expression: role of cytokine modulation and effects on viral penetration.
    Br J Dermatol. 2016 Aug 30. doi: 10.1111/bjd.15010.
    PubMed     Text format     Abstract available


  394. KANG H, Li X, Zhou Q, Quan S, et al
    Exploration of Candidate Biomarkers for Human Psoriasis Based on GC-MS Serum Metabolomics.
    Br J Dermatol. 2016 Aug 26. doi: 10.1111/bjd.15008.
    PubMed     Text format     Abstract available


  395. HUARD C, Gulla SV, Bennett DV, Coyle AJ, et al
    Correlation of Cutaneous Disease Activity with Type 1 Interferon Gene Signature and Interferon Beta in Dermatomyositis.
    Br J Dermatol. 2016 Aug 26. doi: 10.1111/bjd.15006.
    PubMed     Text format     Abstract available


  396. VAN DEN REEK JM, Coenen MJ, van de L'Isle Arias M, Zweegers J, et al
    Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.
    Br J Dermatol. 2016 Aug 26. doi: 10.1111/bjd.15005.
    PubMed     Text format     Abstract available


  397. SALEM A, Rozov S, Al-Samadi A, Stegajev V, et al
    Histamine metabolism and transport are deranged in human keratinocytes in oral lichen planus.
    Br J Dermatol. 2016 Aug 20. doi: 10.1111/bjd.14995.
    PubMed     Text format     Abstract available


  398. JANSE IC, Blok JL, Diercks GF, Horvath B, et al
    Hidradenitis suppurativa: A disease of infundibular epidermis, rather than pilosebaceous units?
    Br J Dermatol. 2016 Aug 20. doi: 10.1111/bjd.14992.
    PubMed     Text format     Abstract available


  399. KOHL E, Popp C, Zeman F, Unger P, et al
    Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo-controlled study.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14970.
    PubMed     Text format     Abstract available


  400. ORTEGA-RECALDE O, Silgado D, Fetiva C, Fonseca DJ, et al
    Transcriptome analysis of skin in a case of Ichthyosis Curth-Macklin caused by a KRT1 mutation.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14969.
    PubMed     Text format     Abstract available


  401. SZABO K, Erdei L, Bolla BS, Tax G, et al
    Factors shaping the composition of the cutaneous microbiota.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14967.
    PubMed     Text format     Abstract available


  402. REICH K, Blauvelt A, Armstrong A, Langley RG, et al
    Secukinumab, a Fully Human Anti-Interleukin-17A Monoclonal Antibody, Exhibits Minimal Immunogenicity in Subjects with Moderate to Severe Plaque Psoriasis.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14965.
    PubMed     Text format     Abstract available


  403. RUNGAPIROMNAN W, Yiu ZZ, Warren RB, Griffiths CE, et al
    Impact of Biologic Therapies on Risk of Major Adverse Cardiovascular Events in Patients with Psoriasis: Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14964.
    PubMed     Text format     Abstract available


  404. GREWAL SK, Wan J, Denburg MR, Shin DB, et al
    The risk of IgA nephropathy and glomerular disease in patients with psoriasis: A population based cohort study.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14961.
    PubMed     Text format     Abstract available


  405. CHIESA FUXENCH ZC, Troxel AB, Gelfand JM
    Validity of diagnosis codes for identifying cutaneous squamous cell carcinoma in The Health Improvement Network.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14957.
    PubMed     Text format     Abstract available


  406. SCHAPER K, Kother B, Hesse K, Satzger I, et al
    The Pattern and Clinicopathological Correlates of PD-L1 Expression in Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14955.
    PubMed     Text format     Abstract available


  407. VON DEM BORNE PA, Jonkman MF, van Doorn R
    Complete remission of skin lesions in a patient with subcorneal pustular dermatosis (Sneddon-Wilkinson disease) treated with anti-myeloma therapy: association with disappearance of M-protein.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14954.
    PubMed     Text format     Abstract available


  408. RIBERO S, Marra E, Tomasini CF, Fierro MT, et al
    Confocal microscopy and dermoscopy for the monitoring of BRAF inhibitor therapy of melanoma skin metastases.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14951.
    PubMed     Text format     Abstract available


  409. MROWIETZ U, Szepietowski JC, Loewe R, Van de Kerkhof P, et al
    Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: A randomised, double-blind, Fumaderm(R) and placebo-controlled trial (BRIDGE).
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14947.
    PubMed     Text format     Abstract available


  410. LANGTON AK, Tsoureli-Nikita E, Griffiths CE, Antoniou C, et al
    Lysyl oxidase activity in human skin is increased by chronic UV-exposure and smoking.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14959.
    PubMed     Text format     Abstract available


  411. HOORENS I, Brochez L
    Chemoprevention of basal cell carcinoma: reply from authors.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14945.
    PubMed     Text format     Abstract available


  412. BOCCARA O, Hadj-Rabia S, Bourrat E, Coulombe J, et al
    Lymphoedema is a potential sequela of Kaposiform haemangioendothelioma: reply from the authors.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14817.
    PubMed     Text format    


  413. ALI FR, Craythorne EE, Al-Niaimi F
    Chemoprevention of basal cell carcinoma.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14937.
    PubMed     Text format     Abstract available


  414. CANUETO J, Cardenoso E, Garcia JL, Santos-Briz A, et al
    EGFR expression is associated with poor outcome in cutaneous squamous cell carcinoma.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14936.
    PubMed     Text format     Abstract available


  415. PAPO M, Valeyrie-Allanore L, Razazi K, Carteaux G, et al
    Renal replacement therapy during Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients.
    Br J Dermatol. 2016 Aug 11. doi: 10.1111/bjd.14934.
    PubMed     Text format     Abstract available


  416. AMITAY-LAISH I, Tavallaee M, Kim J, Hoppe RT, et al
    Paediatric primary cutaneous marginal zone B-cell lymphoma: Does it differ from the adult counterpart?
    Br J Dermatol. 2016 Aug 8. doi: 10.1111/bjd.14932.
    PubMed     Text format     Abstract available


  417. MISHRA S, Kancharla H, Dogra S, Sharma A, et al
    Comparison of the Four Validated Psoriatic Arthritis Screening Tools in Diagnosing Psoriatic Arthritis in Patients with Psoriasis [COMPAQ Study].
    Br J Dermatol. 2016 Aug 8. doi: 10.1111/bjd.14929.
    PubMed     Text format     Abstract available


  418. LUBEEK SF, Borgonjen RJ, van Vugt LJ, Olde Rikkert MG, et al
    Improving the applicability of guidelines on nonmelanoma skin cancer in frail older adults: a multidisciplinary expert consensus and systematic review of current guidelines.
    Br J Dermatol. 2016 Aug 3. doi: 10.1111/bjd.14923.
    PubMed     Text format     Abstract available


  419. KUMARI V, Timm K, Kuhl AA, Heine G, et al
    Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
    Br J Dermatol. 2016 Aug 2. doi: 10.1111/bjd.14921.
    PubMed     Text format     Abstract available


  420. COIMBRA S, Oliveira H, Rocha-Pereira P, Figueiredo A, et al
    The crosstalk between renal function, inflammation and psoriasis vulgaris.
    Br J Dermatol. 2016 Aug 1. doi: 10.1111/bjd.14913.
    PubMed     Text format     Abstract available


  421. WEI T, Folkersen L, Biskup E, Xu N, et al
    USP2 as a potential link between miR-125b and psoriasis.
    Br J Dermatol. 2016 Aug 1. doi: 10.1111/bjd.14916.
    PubMed     Text format     Abstract available


  422. RIBERO S, Osella-Abate S, Reyes-Garcia D, Grulich A, et al
    Gender effects on naevi body distribution and melanoma risk in two melanoma case control studies at different latitudes.
    Br J Dermatol. 2016 Aug 1. doi: 10.1111/bjd.14915.
    PubMed     Text format     Abstract available


  423. KIM J, Han Y, Ahn JH, Kim SW, et al
    Airborne formaldehyde causes skin barrier dysfunction in atopic dermatitis.
    Br J Dermatol. 2016;175:357-63.
    PubMed     Text format     Abstract available


  424. KEMPF W
    TOX - what role does it play in cutaneous lymphomas?
    Br J Dermatol. 2016;175:248-9.
    PubMed     Text format    


  425. EGEBERG A
    Predictors of drug survival for tumour necrosis factor-alpha and interleukin 12/23 antagonists in psoriasis.
    Br J Dermatol. 2016;175:247-8.
    PubMed     Text format    


  426. ORTIZ-ROMERO PL
    Targeting KIR3DL2 in primary cutaneous anaplastic large cell lymphomas.
    Br J Dermatol. 2016;175:246-7.
    PubMed     Text format    


  427. DYRING-ANDERSEN B
    The evolving regulatory role of ubiquitin-editing enzyme A20 in psoriasis during calcipotriol treatment.
    Br J Dermatol. 2016;175:245-6.
    PubMed     Text format    


  428. ORMEROD AD
    Brodalumab established as an effective interleukin-17 receptor antagonist in psoriasis.
    Br J Dermatol. 2016;175:243-4.
    PubMed     Text format    


  429. WALSH S, Lew T, Lee HY
    Psychological sequelae of toxic epidermal necrolysis: further insights.
    Br J Dermatol. 2016;175:241.
    PubMed     Text format    


  430. WELZEL J
    Reflectance confocal microscopy: new micromorphological insights into inflammatory skin diseases.
    Br J Dermatol. 2016;175:239-40.
    PubMed     Text format    


    July 2016
  431. MANGAS C, Potrony M, Mainetti C, Bianchi E, et al
    Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
    Br J Dermatol. 2016 Jul 30. doi: 10.1111/bjd.14897.
    PubMed     Text format     Abstract available


  432. BLANCO I, Lipsker D, Lara B, Janciauskiene S, et al
    Neutrophilic panniculitis and autoinflammation: what's the link?: reply from authors.
    Br J Dermatol. 2016 Jul 27. doi: 10.1111/bjd.14614.
    PubMed     Text format    


  433. THEODORAKOPOULOU E, Yiu ZZ, Bundy C, Chularojanamontri L, et al
    Early and late onset psoriasis: a cross-sectional clinical and immunocytochemical investigation.
    Br J Dermatol. 2016 Jul 26. doi: 10.1111/bjd.14886.
    PubMed     Text format     Abstract available


  434. ZWEEGERS J, Roosenboom B, van de Kerkhof PC, van den Reek JM, et al
    Frequency of and predictors for a high clinical response in psoriasis patients on biologic therapy in daily practice.
    Br J Dermatol. 2016 Jul 25. doi: 10.1111/bjd.14888.
    PubMed     Text format     Abstract available


  435. WILLIS CM, Britton LE, Swindells MA, Jones EM, et al
    Invasive melanoma in-vivo can be distinguished from basal cell carcinoma, benign naevi and healthy skin by canine olfaction: a proof of principle study of differential volatile organic compound emission.
    Br J Dermatol. 2016 Jul 25. doi: 10.1111/bjd.14887.
    PubMed     Text format     Abstract available


  436. GRUBER R, Rainer G, Weiss A, Udvardi A, et al
    Morphological alterations in two siblings with autosomal recessive congenital ichthyosis associated with CYP4F22 mutations.
    Br J Dermatol. 2016 Jul 23. doi: 10.1111/bjd.14860.
    PubMed     Text format     Abstract available


  437. MCGOVERN JA, Meinert C, de Veer SJ, Hollier BG, et al
    Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
    Br J Dermatol. 2016 Jul 21. doi: 10.1111/bjd.14879.
    PubMed     Text format     Abstract available


  438. LEE E, Choi SY, Bin BH, Kim NH, et al
    ITAC induces the melanocytic migration and hypopigmentation through destabilizing p53 via HDAC5: A possible role of ITAC in pigment-related disorders.
    Br J Dermatol. 2016 Jul 20. doi: 10.1111/bjd.14878.
    PubMed     Text format     Abstract available


  439. VAN BEUGEN S, van Middendorp H, Ferwerda M, Smit JV, et al
    Predictors of perceived stigmatization in patients with psoriasis.
    Br J Dermatol. 2016 Jul 20. doi: 10.1111/bjd.14875.
    PubMed     Text format     Abstract available


  440. CHALMERS JR, Simpson E, Apfelbacher CJ, Thomas KS, et al
    Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
    Br J Dermatol. 2016 Jul 19. doi: 10.1111/bjd.14773.
    PubMed     Text format     Abstract available


  441. BISSONNETTE R, Papp KA, Poulin Y, Gooderham M, et al
    Topical tofacitinib for atopic dermatitis: A Phase 2a randomised trial.
    Br J Dermatol. 2016 Jul 16. doi: 10.1111/bjd.14871.
    PubMed     Text format     Abstract available


  442. GRANT WB
    Increased risk of non-cutaneous malignancy after diagnosis of non-melanoma skin cancer may be due to sun avoidance.
    Br J Dermatol. 2016 Jul 15. doi: 10.1111/bjd.14862.
    PubMed     Text format     Abstract available


  443. OGUNSANYA ME, Kalb SJ, Kabaria A, Chen S, et al
    A Systematic Review of Patient-Reported Outcomes (PROs) in Patients with Cutaneous Lupus Erythematosus (CLE).
    Br J Dermatol. 2016 Jul 15. doi: 10.1111/bjd.14868.
    PubMed     Text format     Abstract available


  444. DE VRIES AC, Thio HB, de Kort WJ, Opmeer BC, et al
    A prospective randomised controlled trial comparing infliximab and etanercept in patients with moderate to severe chronic plaque type psoriasis Psoriasis Infliximab versus Etanercept Comparison Evaluation, the PIECE study.
    Br J Dermatol. 2016 Jul 15. doi: 10.1111/bjd.14867.
    PubMed     Text format     Abstract available


  445. FELTON SJ, Cooke MS, Kift R, Berry JL, et al
    Concurrent beneficial (vitamin D production) and hazardous (cutaneous DNA damage) impact of repeated low-level summer sunlight exposures.
    Br J Dermatol. 2016 Jul 14. doi: 10.1111/bjd.14863.
    PubMed     Text format     Abstract available


  446. BATTISTELLA M, Salle de Chou C, de Bazelaire C, Cayuela JM, et al
    Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging.
    Br J Dermatol. 2016 Jul 5. doi: 10.1111/bjd.14850.
    PubMed     Text format     Abstract available


  447. PARDO LM, van der Leest RJ, de Vries E, Soerjomataram I, et al
    Comparing survival of patients with single or multiple primary melanoma in The Netherlands: 1994-2009.
    Br J Dermatol. 2016 Jul 5. doi: 10.1111/bjd.14846.
    PubMed     Text format     Abstract available


  448. CHONG HT, Yang GN, Sidhu S, Ibbetson J, et al
    Reducing Flightless I expression decreases severity of psoriasis in an imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2016 Jul 4. doi: 10.1111/bjd.14842.
    PubMed     Text format     Abstract available


  449. CHISHOLM A, Nelson PA, Pearce CJ, Littlewood AJ, et al
    Motivational interviewing-based training enhances clinicians' skills and knowledge in psoriasis: findings from the Pso Well(R) study.
    Br J Dermatol. 2016 Jul 4. doi: 10.1111/bjd.14837.
    PubMed     Text format     Abstract available


  450. LAMB RC, Matcham F, Turner M, Rayner L, et al
    Screening for Anxiety and Depression in people with psoriasis: a cross sectional study in a tertiary referral setting.
    Br J Dermatol. 2016 Jul 1. doi: 10.1111/bjd.14833.
    PubMed     Text format     Abstract available


  451. LEE KH, Ng YP, Cheah PS, Lim CK, et al
    Molecular characterization of glycation-associated skin ageing: An alternative skin model to study topical anti-glycation activity in vitro of a cosmeceutical and pharmaceutical formulation.
    Br J Dermatol. 2016 Jul 1. doi: 10.1111/bjd.14832.
    PubMed     Text format     Abstract available


  452. KIRBY LC, Banerjee A, Augustine T, Douglas JF, et al
    An ethical dilemma: malignant melanoma in a 51-year-old patient awaiting simultaneous kidney and pancreas transplantation for type 1 diabetes.
    Br J Dermatol. 2016;175:172-4.
    PubMed     Text format     Abstract available


  453. WARREN RB, Weatherhead SC, Smith CH, Exton LS, et al
    British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
    Br J Dermatol. 2016;175:23-44.
    PubMed     Text format    


  454. MOLIN S
    Deciphering the lipidomic profile of irritant contact dermatitis.
    Br J Dermatol. 2016;175:20-1.
    PubMed     Text format    


  455. RYAN C, Menter A
    Discordance between physician assessment of psoriasis and patient self-assessment: the importance of itch.
    Br J Dermatol. 2016;175:19-20.
    PubMed     Text format    


  456. WU KC, Reynolds NJ
    CARD14 mutations may predict response to antitumour necrosis factor-alpha therapy in psoriasis: a potential further step towards personalized medicine.
    Br J Dermatol. 2016;175:17-8.
    PubMed     Text format    


  457. HEERINGA JJ, van Zelm MC
    Is there a pathogenic role for IgE in psoriasis?
    Br J Dermatol. 2016;175:16-7.
    PubMed     Text format    


  458. SCARISBRICK JJ
    Cutaneous T-cell lymphomas: an urgent need for more improved therapies.
    Br J Dermatol. 2016;175:14-5.
    PubMed     Text format    


  459. CHALMERS RJ
    The expanding role of methotrexate for treating skin disease.
    Br J Dermatol. 2016;175:9-10.
    PubMed     Text format    


    June 2016
  460. BANNER A, Dinsey M, Ezzedine K, Dadzie OE, et al
    The Spectrum of Skin Diseases Occurring in a Multi-Ethnic Population in Northwest London, UK; Findings of a Cross-Sectional Descriptive Study.
    Br J Dermatol. 2016 Jun 25. doi: 10.1111/bjd.14824.
    PubMed     Text format     Abstract available


  461. SCHLAGER JG, Rosumeck S, Werner RN, Jacobs A, et al
    Topical treatments for scalp psoriasis - summary of a Cochrane Systematic Review.
    Br J Dermatol. 2016 Jun 17. doi: 10.1111/bjd.14811.
    PubMed     Text format     Abstract available


  462. TEY HL, Nattkemper LA, Cao T, Pramono ZA, et al
    Interleukin-31 receptor and pruritus associated with primary localized cutaneous amyloidosis: reply from the authors.
    Br J Dermatol. 2016 Jun 17. doi: 10.1111/bjd.14774.
    PubMed     Text format    


  463. SHITARA D, Tell-Marti G, Badenas C, Enokihara MM, et al
    Discrepant mutational status between naevi and melanomas in naevus-associated melanomas: about mutation-specific immunohistochemistry: reply from the authors.
    Br J Dermatol. 2016 Jun 16. doi: 10.1111/bjd.14613.
    PubMed     Text format    


  464. DODIUK-GAD RP, Olteanu C, Feinstein A, Hashimoto R, et al
    Major psychological complications and decreased health related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14799.
    PubMed     Text format     Abstract available


  465. GOMEZ-GARCIA F, Epstein D, Isla-Tejera B, Lorente A, et al
    Short-term efficacy and safety of new biologic agents targeting IL-23/Th17 pathway for moderate to severe plaque psoriasis: a systematic review and network meta-analysis.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14814.
    PubMed     Text format     Abstract available


  466. GONZALEZ JM, Johnson FR, McAteer H, Posner J, et al
    Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the UK: results from a discrete-choice experiment.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14798.
    PubMed     Text format     Abstract available


  467. BISSONNETTE R, Cademartiti F, Maffei E, Tardif JC, et al
    Increase in coronary atherosclerosis severity and the prevalence of coronary artery mixed plaques in patients with psoriasis.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14797.
    PubMed     Text format     Abstract available


  468. HAMMILL A, Mobberley-Schuman P, Adams D
    Lymphoedema is a potential sequela of Kaposiform Hemangioendothelioma.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14810.
    PubMed     Text format     Abstract available


  469. SAITO R, Boyce A, Hsu CK, Rashidghamat E, et al
    Predictive phenotyping of inherited ichthyosis by next generation DNA sequencing.
    Br J Dermatol. 2016 Jun 13. doi: 10.1111/bjd.14807.
    PubMed     Text format     Abstract available


  470. LYNCH MD, White JM, McFadden JP, Wang Y, et al
    A dynamic landscape of allergen associations in delayed-type cutaneous hypersensitivity.
    Br J Dermatol. 2016 Jun 10. doi: 10.1111/bjd.14793.
    PubMed     Text format     Abstract available


  471. MARTINS DA SILVA V, Kinsler V
    Infantile haemangiomas do not occur more frequently in children with congenital melanocytic naevi.
    Br J Dermatol. 2016 Jun 8. doi: 10.1111/bjd.14791.
    PubMed     Text format     Abstract available


  472. TEULINGS HE, Lommerts JE, Wolkerstorfer A, Nieuweboer-Krobotova L, et al
    Vitiligo-like depigmentations as first sign of melanoma; a retrospective case series from a tertiary vitiligo centre.
    Br J Dermatol. 2016 Jun 7. doi: 10.1111/bjd.14790.
    PubMed     Text format     Abstract available


  473. WANG CC, Tang CH, Wang CY, Huang SY, et al
    Risk of skin cancer in chronic haemodialysis patients: a nationwide, population-based study in Taiwan.
    Br J Dermatol. 2016 Jun 7. doi: 10.1111/bjd.14789.
    PubMed     Text format     Abstract available


  474. ALI FM, Cueva AC, Vyas J, Atwan AA, et al
    A systematic review of the use of quality of life instruments in randomised controlled trials of psoriasis.
    Br J Dermatol. 2016 Jun 7. doi: 10.1111/bjd.14788.
    PubMed     Text format     Abstract available


  475. HASHIMOTO T, Teye K, Ishii N
    Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University.
    Br J Dermatol. 2016 Jun 3. doi: 10.1111/bjd.14780.
    PubMed     Text format     Abstract available


  476. LLAMAS-VELASCO M, Bonay P, Jose Concha-Garzon M, Corvo-Villen L, et al
    Immune cells from Psoriasis patients are defective to induce Indoleamine 2,3-dioxygenase expression in response to inflammatory stimuli.
    Br J Dermatol. 2016 Jun 3. doi: 10.1111/bjd.14779.
    PubMed     Text format     Abstract available


  477. GARCIA-DOVAL I, Hernandez MV, Vanaclocha F, Sellas A, et al
    Should TNF-antagonists safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis Biobadaser and psoriasis Biobadaderm cohorts.
    Br J Dermatol. 2016 Jun 3. doi: 10.1111/bjd.14776.
    PubMed     Text format     Abstract available


  478. HUGUEN J, Bonsang B, Lemasson G, Misery L, et al
    Image Gallery: Acroangiodermatitis or pseudo-Kaposi sarcoma: two cases in patients with paralyzed legs.
    Br J Dermatol. 2016;174:e84.
    PubMed     Text format    


  479. HUANG YT, Liao CH, Hsueh PR
    Image Gallery: Cutaneous infections caused by Alternaria alternata and Mucor irregularis 1 year apart in a patient with iatrogenic Cushing syndrome.
    Br J Dermatol. 2016;174:e82.
    PubMed     Text format    


  480. CREAMER D, Walsh SA, Dziewulski P, Exton LS, et al
    U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Br J Dermatol. 2016;174:1194-227.
    PubMed     Text format    


  481. YAMANAKA K, Mizutani H
    A new biomarker for psoriasis.
    Br J Dermatol. 2016;174:1191-2.
    PubMed     Text format    


  482. STEFANAKI I, Stratigos AJ
    Inherited susceptibility to melanoma: insights from a high-risk Austrian cohort.
    Br J Dermatol. 2016;174:1188-90.
    PubMed     Text format    


  483. MELNIK BC
    Acne vulgaris: an inflammasomopathy of the sebaceous follicle induced by deviated FoxO1/mTORC1 signalling.
    Br J Dermatol. 2016;174:1186-8.
    PubMed     Text format    


  484. ALBRECHT J, Gerdes S
    A new option on the horizon for the treatment of psoriasis: it is needed, but not at any price.
    Br J Dermatol. 2016;174:1183-4.
    PubMed     Text format    


  485. WISCO OJ, Adelson D
    Basal cell carcinoma screening drives a comprehensive approach to skin cancer.
    Br J Dermatol. 2016;174:1182-3.
    PubMed     Text format    


  486. LINOS E, Chren MM
    Is screening for basal cell carcinoma worthwhile? Too soon to tell.
    Br J Dermatol. 2016;174:1181-2.
    PubMed     Text format    


  487. DOWLATSHAHI EA, Wakkee M
    Rising interest in the field of paediatric psoriasis.
    Br J Dermatol. 2016;174:1180-1.
    PubMed     Text format    


  488. BUNDY C
    Is education enough to improve quality of life in people with chronic inflammatory skin conditions?
    Br J Dermatol. 2016;174:1179.
    PubMed     Text format    


  489. COATES LC, Murphy R, Helliwell PS
    New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation.
    Br J Dermatol. 2016;174:1174-8.
    PubMed     Text format    


  490. WOLKENSTEIN P, Wilson YT
    Toxic epidermal necrolysis: the past, the guidelines and challenges for the future.
    Br J Dermatol. 2016;174:1171-3.
    PubMed     Text format    


    May 2016
  491. PIRMEZ R, Duque-Estrada B, Donati A, Campos-do-Carmo G, et al
    Clinical and dermoscopic features of lichen planus pigmentosus in 37 patients with frontal fibrosing alopecia.
    Br J Dermatol. 2016 May 28. doi: 10.1111/bjd.14722.
    PubMed     Text format     Abstract available


  492. LUBEEK SF, Arnold WP
    A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma.
    Br J Dermatol. 2016 May 27. doi: 10.1111/bjd.14770.
    PubMed     Text format     Abstract available


  493. RANSOHOFF KJ, Stefanick ML, Li S, Kurian AW, et al
    Association of non-melanoma skin cancer with second non-cutaneous malignancy in the Women's Health Initiative.
    Br J Dermatol. 2016 May 26. doi: 10.1111/bjd.14766.
    PubMed     Text format     Abstract available


  494. PETRELLI F, Borgonovo K, Cabiddu M, Coinu A, et al
    Antibiotic prophylaxis for skin toxicity induced by anti-EGFR agents: a systematic review and meta-analysis.
    Br J Dermatol. 2016 May 23. doi: 10.1111/bjd.14756.
    PubMed     Text format     Abstract available


  495. TRAUTMANN F, Meier F, Seidler A, Schmitt J, et al
    Effects of the German skin cancer screening program on melanoma incidence and indicators of disease severity.
    Br J Dermatol. 2016 May 20. doi: 10.1111/bjd.14758.
    PubMed     Text format     Abstract available


  496. DOWLATSHAHI EA, Hollestein LM, Herings RM, Nijsten T, et al
    Increased overall drug utilization in psoriasis patients: a case-control study based on Dutch general practitioner data.
    Br J Dermatol. 2016 May 20. doi: 10.1111/bjd.14754.
    PubMed     Text format     Abstract available


  497. GUITERA P, Menzies SW, Argenziano G, Longo C, et al
    Dermoscopy and in vivo confocal microscopy are complimentary techniques for the diagnosis of difficult amelanotic and light colored skin lesions.
    Br J Dermatol. 2016 May 13. doi: 10.1111/bjd.14749.
    PubMed     Text format     Abstract available


  498. DESNOYER A, Dupin N, Assoumou L, Carlotti A, et al
    Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi's sarcoma skin lesions.
    Br J Dermatol. 2016 May 13. doi: 10.1111/bjd.14748.
    PubMed     Text format     Abstract available


  499. THURNEYSEN S, Cheng PF, Nagel HW, Kunz M, et al
    An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel.
    Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14727.
    PubMed     Text format     Abstract available


  500. NATHAN N, Burke K, Moss J, Darling TN, et al
    A diagnostic and management algorithm for individuals with an isolated skin finding suggestive of tuberous sclerosis complex.
    Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14724.
    PubMed     Text format     Abstract available


  501. MCCONNELL AT, Ellis R, Pathy B, Plummer R, et al
    The prognostic significance and impact of the CXCR4/CXCR7/CXCL12 axis in primary cutaneous melanoma.
    Br J Dermatol. 2016 May 11. doi: 10.1111/bjd.14720.
    PubMed     Text format     Abstract available


  502. CIZENSKI J, Griffin J, Menter A
    Image Gallery: Cutaneous T-cell lymphoma mimicking a gyrate erythema.
    Br J Dermatol. 2016;174:e42.
    PubMed     Text format    


  503. PIANA S, Moscarella E, Longo C
    Image Gallery: Brain? no, melanoma.
    Br J Dermatol. 2016;174:e41.
    PubMed     Text format    


  504. HARRIS AG, Choy C, Pigors M, Kelsell DP, et al
    Cover image: Unpeeling the layers of harlequin ichthyosis.
    Br J Dermatol. 2016;174:1160-1.
    PubMed     Text format    


  505. YOUN SW
    A prelude to a functional noninvasive in vivo diagnostic tool for skin diseases.
    Br J Dermatol. 2016;174:961.
    PubMed     Text format    


  506. BEWLEY AP
    Cutaneous lupus erythematosus is strongly associated with psychiatric disease.
    Br J Dermatol. 2016;174:958-9.
    PubMed     Text format    


  507. KURSCHUS F
    Of men and mice: analysing the action of an established drug using tumour necrosis factor-alpha-deficient mice in the imiquimod psoriasis model.
    Br J Dermatol. 2016;174:955-6.
    PubMed     Text format    


  508. SCHOFIELD JK, Robinson R, Reeken S, Jackson R, et al
    National Institute for Health and Care Excellence melanoma guidelines: good news for patients but challenging to implement.
    Br J Dermatol. 2016;174:949-50.
    PubMed     Text format    


  509. WIEGELL SR, Petersen B, Wulf HC
    Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
    Br J Dermatol. 2016;174:979-84.
    PubMed     Text format     Abstract available


  510. INGRAM JR, Woo PN, Chua SL, Ormerod AD, et al
    Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.
    Br J Dermatol. 2016;174:970-8.
    PubMed     Text format     Abstract available


  511. WHITTON M, Pinart M, Batchelor JM, Leonardi-Bee J, et al
    Evidence-based management of vitiligo: summary of a Cochrane systematic review.
    Br J Dermatol. 2016;174:962-9.
    PubMed     Text format     Abstract available


  512. LAPI F, Cassano N, Pegoraro V, Cataldo N, et al
    Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy.
    Br J Dermatol. 2016;174:996-1004.
    PubMed     Text format     Abstract available


  513. LLOYD-LAVERY A, Hodgson T, Coupe N, Bond S, et al
    Delayed oral toxicity from long-term vemurafenib therapy.
    Br J Dermatol. 2016;174:1159-60.
    PubMed     Text format    


  514. LALLAS A, Tschandl P, Kyrgidis A, Stolz W, et al
    Dermoscopic clues to differentiate facial lentigo maligna from pigmented actinic keratosis.
    Br J Dermatol. 2016;174:1079-85.
    PubMed     Text format     Abstract available


  515. GUTIERREZ-HERRERA E, Ortiz AE, Doukas A, Franco W, et al
    Fluorescence excitation photography of epidermal cellular proliferation.
    Br J Dermatol. 2016;174:1086-91.
    PubMed     Text format     Abstract available


  516. GOHAR A
    Control of tinea capitis.
    Br J Dermatol. 2016;174:1158.
    PubMed     Text format    


  517. ZIMMER S, Peveling-Oberhag A, Weber A, Gilfert T, et al
    Unique coexistence of cold and solar urticaria and its efficient treatment.
    Br J Dermatol. 2016;174:1150-2.
    PubMed     Text format    


  518. ALI S, Kelly C, Challacombe SJ, Donaldson AN, et al
    Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid.
    Br J Dermatol. 2016;174:1022-9.
    PubMed     Text format     Abstract available


  519. ZHAO Y, Li CY, Wen CM, Wei YB, et al
    The prevalence of actinic keratosis in patients visiting dermatologists in two hospitals in China.
    Br J Dermatol. 2016;174:1005-10.
    PubMed     Text format     Abstract available


  520. SCHLIPF NA, Traupe H, Gilaberte Y, Peitsch WK, et al
    Association of Cole disease with novel heterozygous mutations in the somatomedin-B domains of the ENPP1 gene: necessary, but not always sufficient.
    Br J Dermatol. 2016;174:1152-6.
    PubMed     Text format    


  521. PARK HK, Kim EJ, Ko JY
    Alitretinoin: treatment for refractory palmoplantar keratoderma.
    Br J Dermatol. 2016;174:1143-4.
    PubMed     Text format    


  522. GREVELING K, de Vries K, van Doorn MB, Prens EP, et al
    A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.
    Br J Dermatol. 2016;174:1134-6.
    PubMed     Text format    


  523. BARRICK BJ, Barrick JD, Weaver CH, Lohse CM, et al
    Herpes zoster in patients with bullous pemphigoid: a population-based case-control and cohort study.
    Br J Dermatol. 2016;174:1112-4.
    PubMed     Text format    


  524. HAWKEY S, Abdul Ghaffar S
    Glove-related hand urticaria: an increasing occupational problem among healthcare workers.
    Br J Dermatol. 2016;174:1137-40.
    PubMed     Text format    


  525. TURCZYNSKI S, Titeux M, Pironon N, Cohn HI, et al
    Marked intrafamilial phenotypic heterogeneity in dystrophic epidermolysis bullosa caused by inheritance of a mild dominant glycine substitution and a novel deep intronic recessive COL7A1 mutation.
    Br J Dermatol. 2016;174:1122-5.
    PubMed     Text format    


  526. MUN JH, Park SM, Kim GW, Song M, et al
    Clinical and dermoscopic characteristics of extramammary Paget disease: a study of 35 cases.
    Br J Dermatol. 2016;174:1104-7.
    PubMed     Text format    


  527. RAY S, Belch JJ, Craigie AM, Khan F, et al
    Can antioxidant-rich blackcurrant juice drink consumption improve photoprotection against ultraviolet radiation?
    Br J Dermatol. 2016;174:1101-3.
    PubMed     Text format    


  528. DYRING-ANDERSEN B, Kamp S, Madelung A, Zachariae C, et al
    Unilateral hyperhidrosis and hypothermia: symptoms of an intrathoracic tumour.
    Br J Dermatol. 2016;174:1147-8.
    PubMed     Text format    


    April 2016
  529. ROMITI R, Gavioli CF, Anzai A, Donati A, et al
    Image Gallery: Exuberant tufted folliculitis affecting the scalp.
    Br J Dermatol. 2016;174:e22.
    PubMed     Text format    


  530. GOLOGORSKY D, Gregori NZ, Goldhardt R
    Image Gallery: Dermatologic and retinal manifestations of pseudoxanthoma elasticum.
    Br J Dermatol. 2016;174:e21.
    PubMed     Text format    


  531. POPE V, Dupuis L, Kannu P, Mendoza-Londono R, et al
    Buschke-Ollendorff syndrome: a novel case series and systematic review.
    Br J Dermatol. 2016;174:723-9.
    PubMed     Text format     Abstract available


  532. OH SJ, Lee SE, Hashimoto T, Kim SC, et al
    A case of paraneoplastic pemphigus associated with Castleman disease reacting with multiple autoantigens, including the p200 protein.
    Br J Dermatol. 2016;174:930-2.
    PubMed     Text format    


  533. IRANZO P, Alsina-Gibert M
    Immunobullous disease and ulcerative colitis - the need of an accurate diagnosis.
    Br J Dermatol. 2016;174:934-5.
    PubMed     Text format    


  534. NILSEN LT, Hannevik M, Veierod MB
    Ultraviolet exposure from indoor tanning devices: a systematic review.
    Br J Dermatol. 2016;174:730-40.
    PubMed     Text format     Abstract available


  535. PARISER DM, Eichenfield LF, Bukhalo M, Waterman G, et al
    Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
    Br J Dermatol. 2016;174:770-7.
    PubMed     Text format     Abstract available


  536. ISEDEH P, Kohli I, Al-Jamal M, Agbai ON, et al
    An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits.
    Br J Dermatol. 2016;174:862-8.
    PubMed     Text format     Abstract available


  537. BLOK JL, Li K, Brodmerkel C, Horvatovich P, et al
    Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum.
    Br J Dermatol. 2016;174:839-46.
    PubMed     Text format     Abstract available


  538. SAMIMI M, Molet L, Fleury M, Laude H, et al
    Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma.
    Br J Dermatol. 2016;174:813-22.
    PubMed     Text format     Abstract available


  539. SOBOCINSKI V, Duvert-Lehembre S, Bubenheim M, Lesage C, et al
    Assessment of adherence to topical corticosteroids in patients with bullous pemphigoid.
    Br J Dermatol. 2016;174:919-21.
    PubMed     Text format    


  540. VAN GEEL N, Desmedt V, De Schepper S, Boone B, et al
    Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view.
    Br J Dermatol. 2016;174:922-4.
    PubMed     Text format    


  541. POOT AM, Siland J, Jonkman MF, Pas HH, et al
    Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus.
    Br J Dermatol. 2016;174:912-5.
    PubMed     Text format    


  542. ECKERT JC, Ertas B, Falk TM, Metze D, et al
    Species identification of dermatophytes in paraffin-embedded biopsies with a new polymerase chain reaction assay targeting the internal transcribed spacer 2 region and comparison with histopathological features.
    Br J Dermatol. 2016;174:869-77.
    PubMed     Text format     Abstract available


  543. MANSOURI Y, Martin-Clavijo A, Newsome P, Kaur MR, et al
    Dissecting cellulitis of the scalp treated with tumour necrosis factor-alpha inhibitors: experience with two agents.
    Br J Dermatol. 2016;174:916-8.
    PubMed     Text format    


  544. XU H, Xiao X, Hui Y, Zhang X, et al
    Phenotype of 53 Chinese individuals with nicastrin gene mutations in association with familial hidradenitis suppurativa (acne inversa).
    Br J Dermatol. 2016;174:927-9.
    PubMed     Text format    


  545. RING HC, Theut Riis P, Miller IM, Saunte DM, et al
    Self-reported pain management in hidradenitis suppurativa.
    Br J Dermatol. 2016;174:909-11.
    PubMed     Text format    


  546. ARAKAWA M, Ohata C, Tsuruta D, Ishii N, et al
    A severe and prolonged case of pemphigoid gestationis successfully treated with combination therapies.
    Br J Dermatol. 2016;174:925-7.
    PubMed     Text format    


  547. FOO SH, Shah F, Chaganti S, Stevens A, et al
    Unmasking mycosis fungoides/Sezary syndrome from preceding or co-existing benign inflammatory dermatoses requiring systemic therapies: patients frequently present with advanced disease and have an aggressive clinical course.
    Br J Dermatol. 2016;174:901-4.
    PubMed     Text format    


  548. PAUS R, Burgoa I, Platt CI, Griffiths T, et al
    Biology of the eyelash hair follicle: an enigma in plain sight.
    Br J Dermatol. 2016;174:741-52.
    PubMed     Text format     Abstract available


  549. SILPA-ARCHA N, Griffith JL, Williams MS, Lim HW, et al
    Prospective comparison of recipient-site preparation with fractional carbon dioxide laser vs. dermabrasion and recipient-site dressing composition in melanocyte-keratinocyte transplantation procedure in vitiligo: a preliminary study.
    Br J Dermatol. 2016;174:895-7.
    PubMed     Text format    


  550. TANG MF, Sy HY, Kwok JS, Tam WH, et al
    Eczema susceptibility and composition of faecal microbiota at 4 weeks of age: a pilot study in Chinese infants.
    Br J Dermatol. 2016;174:898-900.
    PubMed     Text format    


  551. MAURER M, Staubach P, Raap U, Richter-Huhn G, et al
    ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice.
    Br J Dermatol. 2016;174:892-4.
    PubMed     Text format    


    March 2016
  552. KAMIJO M
    Evaluating the genotypes and neuropsychiatric phenotypes in Darier disease.
    Br J Dermatol. 2016;174:488-9.
    PubMed     Text format    


  553. FREW JW
    Beyond the tip of the iceberg: the role of phosphoinositide 3-kinase/AKT in acne inversa/hidradenitis suppurativa.
    Br J Dermatol. 2016;174:484-5.
    PubMed     Text format    


  554. HAY RJ
    Diagnosing dermatophytic infections in the molecular age.
    Br J Dermatol. 2016;174:483-4.
    PubMed     Text format    


  555. MARZANO AV
    Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what's the link?
    Br J Dermatol. 2016;174:482-3.
    PubMed     Text format    


  556. GARMYN M
    Ingenol mebutate for actinic keratosis: a field-directed therapy with short duration.
    Br J Dermatol. 2016;174:481-2.
    PubMed     Text format    


  557. LANGAN SM, Smeeth L, West J
    Reply to: Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid.
    Br J Dermatol. 2016;174:696-7.
    PubMed     Text format    


  558. SILVERBERG JI, Hsu D, Brieva J
    Reply to: Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid: reply from the authors.
    Br J Dermatol. 2016;174:697.
    PubMed     Text format    


  559. PARTARRIEU-MEJIAS F, Perez-Velasquez F
    Image Gallery: Xeroderma pigmentosum.
    Br J Dermatol. 2016;174:e12.
    PubMed     Text format    


  560. ELBEHAIRY S, Elbendary A, Moussa Z
    Image Gallery: Linear unilateral basaloid follicular hamartoma: a unique presentation.
    Br J Dermatol. 2016;174:e11.
    PubMed     Text format    


  561. PIRMEZ R, Del Rei M
    Cover Image: A dashed hair.
    Br J Dermatol. 2016;174:697-8.
    PubMed     Text format    


  562. GOMEZ-MOYANO E, Crespo Erchiga V, Martinez Pilar L, Martinez Garcia S, et al
    Using dermoscopy to detect tinea of vellus hair.
    Br J Dermatol. 2016;174:636-8.
    PubMed     Text format    


  563. LANGAN SM, Benchimol EI
    The need to improve reporting of routinely collected dermatology data for patient benefit.
    Br J Dermatol. 2016;174:477-80.
    PubMed     Text format    


  564. CHON SY, Hassler AA
    Demodex inflammatory eruption due to epidermal growth factor receptor inhibitor therapy.
    Br J Dermatol. 2016;174:686-7.
    PubMed     Text format    


  565. ROUANET J, Aubin F, Gaboriaud P, Berthon P, et al
    Trichodysplasia spinulosa: a polyomavirus infection specifically targeting follicular keratinocytes in immunocompromised patients.
    Br J Dermatol. 2016;174:629-32.
    PubMed     Text format     Abstract available


  566. DE VRIES K, Greveling K, Prens LM, Munte K, et al
    Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision.
    Br J Dermatol. 2016;174:588-93.
    PubMed     Text format     Abstract available


  567. TAYLOR-ROBINSON DC, Williams H, Pearce A, Law C, et al
    Do early-life exposures explain why more advantaged children get eczema? Findings from the U.K. Millennium Cohort Study.
    Br J Dermatol. 2016;174:569-78.
    PubMed     Text format     Abstract available


  568. ZHONG SY, Dong YY, Liu DX, Xu DH, et al
    Surface air plasma-induced cell death and cytokine release of human keratinocytes in the context of psoriasis.
    Br J Dermatol. 2016;174:542-52.
    PubMed     Text format     Abstract available


  569. WU JH, Nguyen HP, Rady PL, Tyring SK, et al
    Molecular insight into the viral biology and clinical features of trichodysplasia spinulosa.
    Br J Dermatol. 2016;174:490-8.
    PubMed     Text format     Abstract available


  570. SHIN S, Lee JW, Lee Y, Kim DS, et al
    Spontaneous partial regression of naevus of Ota with the development of vitiligo.
    Br J Dermatol. 2016;174:694-5.
    PubMed     Text format    


  571. SELLS RE, Chen CA, Wong MT, Zimarowski MJ, et al
    Continuous positive airway pressure-associated cutaneous amoebiasis in an immunosuppressed patient.
    Br J Dermatol. 2016;174:625-8.
    PubMed     Text format     Abstract available


  572. ARIMA Y, Namiki T, Ueno M, Kato K, et al
    Histiocytoid Sweet syndrome: a novel association with relapsing polychondritis.
    Br J Dermatol. 2016;174:691-4.
    PubMed     Text format    


  573. TANAHASHI K, Sugiura K, Sato T, Akiyama M, et al
    Noteworthy clinical findings of harlequin ichthyosis: digital autoamputation caused by cutaneous constriction bands in a case with novel ABCA12 mutations.
    Br J Dermatol. 2016;174:689-91.
    PubMed     Text format    


  574. RAJAN N, Brown S, Ward S, Hainsworth P, et al
    Mesenteric cysts in naevoid basal cell carcinoma syndrome: a mimic of metastatic disease.
    Br J Dermatol. 2016;174:684-5.
    PubMed     Text format    


  575. XIAO X, He Y, Li C, Zhang X, et al
    Nicastrin mutations in familial acne inversa impact keratinocyte proliferation and differentiation through the Notch and phosphoinositide 3-kinase/AKT signalling pathways.
    Br J Dermatol. 2016;174:522-32.
    PubMed     Text format     Abstract available


  576. WEDGEWORTH E, Glover M, Irvine AD, Neri I, et al
    Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.
    Br J Dermatol. 2016;174:594-601.
    PubMed     Text format     Abstract available


  577. GARBE C, Basset-Seguin N, Poulin Y, Larsson T, et al
    Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0.015% gel: a randomized, controlled 12-month study.
    Br J Dermatol. 2016;174:505-13.
    PubMed     Text format     Abstract available


  578. FRANCO W, Gutierrez-Herrera E, Kollias N, Doukas A, et al
    Review of applications of fluorescence excitation spectroscopy to dermatology.
    Br J Dermatol. 2016;174:499-504.
    PubMed     Text format     Abstract available


  579. DODIUK-GAD RP, Cohen-Barak E, Khayat M, Milo H, et al
    Darier disease in Israel: combined evaluation of genetic and neuropsychiatric aspects.
    Br J Dermatol. 2016;174:562-8.
    PubMed     Text format     Abstract available


  580. GUBAN B, Vas K, Balog Z, Manczinger M, et al
    Abnormal regulation of fibronectin production by fibroblasts in psoriasis.
    Br J Dermatol. 2016;174:533-41.
    PubMed     Text format     Abstract available


  581. LI M, Wang J, Zhang J, Ni C, et al
    Genome-wide linkage and exome sequencing analyses identify an initiation codon mutation of KRT5 in a unique Chinese family with generalized Dowling-Degos disease.
    Br J Dermatol. 2016;174:663-6.
    PubMed     Text format    


  582. LIMA AL, Karl I, Giner T, Poppe H, et al
    Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.
    Br J Dermatol. 2016;174:514-21.
    PubMed     Text format     Abstract available


  583. FEIG JL, Gribetz ME, Lebwohl MG
    Chronic lichen sclerosus successfully treated with intralesional adalimumab.
    Br J Dermatol. 2016;174:687-9.
    PubMed     Text format    


  584. BELLON T, Lerma V, Gonzalez-Valle O, Gonzalez Herrada C, et al
    Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds.
    Br J Dermatol. 2016;174:621-4.
    PubMed     Text format     Abstract available


  585. KURATA M, Horie C, Kano Y, Shiohara T, et al
    Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2016;174:681-3.
    PubMed     Text format    


  586. SBIDIAN E, Hotz C, Seneschal J, Maruani A, et al
    Antitumour necrosis factor-alpha therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013.
    Br J Dermatol. 2016;174:667-70.
    PubMed     Text format    


  587. OHST T, Kupsch C, Graser Y
    Detection of common dermatophytes in clinical specimens using a simple quantitative real-time TaqMan polymerase chain reaction assay.
    Br J Dermatol. 2016;174:602-9.
    PubMed     Text format     Abstract available


  588. MIYAUCHI T, Moriuchi R, Hamade Y, Suzuki S, et al
    Warts in toe webs associated with human papillomavirus type 7: a specific cutaneous manifestation of this type?
    Br J Dermatol. 2016;174:678-81.
    PubMed     Text format    


  589. GERDES S, Dethlefs B, Personke Y, Storim J, et al
    Online weight-loss coaching for patients with psoriasis: results of a pilot study.
    Br J Dermatol. 2016;174:674-6.
    PubMed     Text format    


  590. VERYKIOU S, Oliphant TJ, Rahim R, Husain A, et al
    Diagnostic biopsy before Mohs micrographic surgery, frequency of change in diagnosis and impact on management.
    Br J Dermatol. 2016;174:649-51.
    PubMed     Text format    


  591. HSU D, Brieva J, Nardone B, Silverberg JI, et al
    Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid.
    Br J Dermatol. 2016;174:645-8.
    PubMed     Text format    


  592. LANIOSZ V
    The benefits of the patient experience: one dermatology resident's perspective.
    Br J Dermatol. 2016;174:681.
    PubMed     Text format    


  593. KIM A, Silverberg JI
    A systematic review of vigorous physical activity in eczema.
    Br J Dermatol. 2016;174:660-2.
    PubMed     Text format    


  594. BENNETT MF, Lowney AC, Bourke JF
    A study of occupational contact dermatitis in the pharmaceutical industry.
    Br J Dermatol. 2016;174:654-6.
    PubMed     Text format    


  595. DAUNTON A, Bridgett C, Goulding JM
    Habit reversal for refractory atopic dermatitis: a review.
    Br J Dermatol. 2016;174:657-9.
    PubMed     Text format    


  596. GAMBICHLER T, Mamali K, Patsinakidis N, Moritz R, et al
    Decreased expression of ten-eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoides.
    Br J Dermatol. 2016;174:652-3.
    PubMed     Text format    


  597. RYAN TD, Lucky AW, King EC, Huang G, et al
    Ventricular dysfunction and aortic dilation in patients with recessive dystrophic epidermolysis bullosa.
    Br J Dermatol. 2016;174:671-3.
    PubMed     Text format    


  598. KRENGEL S, Widmer DS, Kerl K, Levesque MP, et al
    Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation.
    Br J Dermatol. 2016;174:642-4.
    PubMed     Text format    


  599. NAGAI H, Oiso N, Tomida S, Sakai K, et al
    Epidermolysis bullosa simplex with mottled pigmentation with noncicatricial alopecia: identification of a recurrent p.P25L mutation in KRT5 in four affected family members.
    Br J Dermatol. 2016;174:633-5.
    PubMed     Text format    


  600. NAZARY M, Prens EP, Boer J
    Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients.
    Br J Dermatol. 2016;174:639-41.
    PubMed     Text format    


    February 2016
  601. HASHIMOTO T, Ohzono A, Ishii N
    'Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus': reply from the authors.
    Br J Dermatol. 2016;174:461-2.
    PubMed     Text format    


  602. AMBER KT
    Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.
    Br J Dermatol. 2016;174:461.
    PubMed     Text format    


  603. JINNIN M
    A possible mechanism of hypercoagulation status in scleroderma.
    Br J Dermatol. 2016;174:263.
    PubMed     Text format    


  604. WERNER RN, Nast A
    Treating actinic keratosis.
    Br J Dermatol. 2016;174:260-1.
    PubMed     Text format    


  605. EZZEDINE K, Pandya A
    Time for a patient-oriented outcome in vitiligo: the vitiligo noticeability scale.
    Br J Dermatol. 2016;174:255-6.
    PubMed     Text format    


  606. LONGO C, Ribero S
    Heritability of naevus pattern.
    Br J Dermatol. 2016;174:265-6.
    PubMed     Text format    


  607. PIRMEZ R, Sodre CT
    Cover Image: Music box spines.
    Br J Dermatol. 2016;174:464-5.
    PubMed     Text format    


  608. LEE S, Duffy DL, McClenahan P, Lee KJ, et al
    Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: a cross-sectional study.
    Br J Dermatol. 2016;174:356-63.
    PubMed     Text format     Abstract available


  609. SINNYA S, Tan JM, Prow TW, Primiero C, et al
    A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis.
    Br J Dermatol. 2016;174:305-11.
    PubMed     Text format     Abstract available


  610. VENTURINI M, Gualdi G, Zanca A, Lorenzi L, et al
    A new approach for presurgical margin assessment by reflectance confocal microscopy of basal cell carcinoma.
    Br J Dermatol. 2016;174:380-5.
    PubMed     Text format     Abstract available


  611. HAUKSSON I, Ponten A, Gruvberger B, Isaksson M, et al
    Skincare products containing low concentrations of formaldehyde detected by the chromotropic acid method cannot be safely used in formaldehyde-allergic patients.
    Br J Dermatol. 2016;174:371-9.
    PubMed     Text format     Abstract available


  612. GUNARATNE DA, Howle JR, Veness MJ
    Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases.
    Br J Dermatol. 2016;174:273-81.
    PubMed     Text format     Abstract available


  613. TIMMERMAN JG, Heederik D, Spee T, van Rooy FG, et al
    Contact dermatitis in the construction industry: the role of filaggrin loss-of-function mutations.
    Br J Dermatol. 2016;174:348-55.
    PubMed     Text format     Abstract available


  614. BATCHELOR JM, Tan W, Tour S, Yong A, et al
    Validation of the Vitiligo Noticeability Scale: a patient-reported outcome measure of vitiligo treatment success.
    Br J Dermatol. 2016;174:386-94.
    PubMed     Text format     Abstract available


  615. NEMOTO O, Furue M, Nakagawa H, Shiramoto M, et al
    The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placeb
    Br J Dermatol. 2016;174:296-304.
    PubMed     Text format     Abstract available


  616. JUNG YS, Kim M, Lee JH, Kim DW, et al
    Acneiform eruptions caused by various second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia.
    Br J Dermatol. 2016;174:456-8.
    PubMed     Text format    


  617. SAIGUSA R, Asano Y, Yamashita T, Taniguchi T, et al
    Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
    Br J Dermatol. 2016;174:338-47.
    PubMed     Text format     Abstract available


  618. GONZALEZ-RAMOS J, Alonso-Pacheco ML, Goiburu-Chenu B, Mayor-Ibarguren A, et al
    Successful treatment of refractory pruritic Fox-Fordyce disease with botulinum toxin type A.
    Br J Dermatol. 2016;174:458-9.
    PubMed     Text format    


  619. DIEPGEN TL, Ofenloch RF, Bruze M, Bertuccio P, et al
    Prevalence of contact allergy in the general population in different European regions.
    Br J Dermatol. 2016;174:319-29.
    PubMed     Text format     Abstract available


  620. AMMAR M, Jordan CT, Cao L, Lim E, et al
    CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
    Br J Dermatol. 2016;174:330-7.
    PubMed     Text format     Abstract available


  621. STINGENI L, Bianchi L, Tramontana M, Moretta I, et al
    Indoor dermatitis due to Aeroglyphus robustus.
    Br J Dermatol. 2016;174:454-6.
    PubMed     Text format    


  622. HONG KK, Gwak MJ, Song J, Kim NI, et al
    Nuclear factor-kappaB pathway activation and phosphatase and tensin homolog downregulation in psoriasis.
    Br J Dermatol. 2016;174:433-5.
    PubMed     Text format    


  623. SCHLIPF NA, Vahlquist A, Teigen N, Virtanen M, et al
    Whole-exome sequencing identifies novel autosomal recessive DSG1 mutations associated with mild SAM syndrome.
    Br J Dermatol. 2016;174:444-8.
    PubMed     Text format    


  624. AHN RS, Moslehi H, Martin MP, Abad-Santos M, et al
    Inhibitory KIR3DL1 alleles are associated with psoriasis.
    Br J Dermatol. 2016;174:449-51.
    PubMed     Text format    


  625. HATA H, Natsuga K, Kitamura S, Imafuku K, et al
    Concomitant neoplasms in the skin and stomach unveil the role of type IV collagen and E-cadherin in mucin core protein 5AC expression in vivo.
    Br J Dermatol. 2016;174:395-7.
    PubMed     Text format     Abstract available


  626. RASHIDGHAMAT E, Ozoemena L, Liu L, McGrath JA, et al
    Mutations in EXPH5 underlie a rare subtype of autosomal recessive epidermolysis bullosa simplex.
    Br J Dermatol. 2016;174:452-3.
    PubMed     Text format    


  627. JERBI M, Ben Rekaya M, Naouali C, Jones M, et al
    Clinical, genealogical and molecular investigation of the xeroderma pigmentosum type C complementation group in Tunisia.
    Br J Dermatol. 2016;174:439-43.
    PubMed     Text format    


  628. KALINSKA-BIENIAS A, Kalowska M, Kwiek B, Jakubowska B, et al
    Efficacy and safety of perilesional/intralesional triamcinolone injections in oral mucous membrane pemphigoid.
    Br J Dermatol. 2016;174:436-8.
    PubMed     Text format    


    January 2016
  629. KOCK M, Coenraads PJ, Blomeke B, Goebel C, et al
    Continuous usage of a hair dye product containing 2-methoxymethyl-p-phenylenediamine by hair dye allergic individuals.
    Br J Dermatol. 2016 Jan 8. doi: 10.1111/bjd.14390.
    PubMed     Text format     Abstract available


  630. CLIFF SH
    Five-year recurrence rate of lentigo maligna after off-label treatment with imiquimod.
    Br J Dermatol. 2016;174:22-3.
    PubMed     Text format    


  631. CALLANDER J, Piguet V
    Amyopathic dermatomyositis: evidence of systemic associations.
    Br J Dermatol. 2016;174:21-2.
    PubMed     Text format    


  632. HAMMERS CM, Stanley JR
    Patients with pemphigus foliaceus may retain antibody reactivity against calcium-stabilized, distal desmoglein 1 domains in remission.
    Br J Dermatol. 2016;174:17-8.
    PubMed     Text format    


  633. WOLF P
    Psoralen-ultraviolet A endures as one of the most powerful treatments in dermatology: reinforcement of this 'triple-product therapy' by the 2016 British guidelines.
    Br J Dermatol. 2016;174:11-4.
    PubMed     Text format    


  634. LING TC, Clayton TH, Crawley J, Exton LS, et al
    British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.
    Br J Dermatol. 2016;174:24-55.
    PubMed     Text format    


  635. KAI AC, Richards T, Coleman A, Mallipeddi R, et al
    Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
    Br J Dermatol. 2016;174:165-8.
    PubMed     Text format     Abstract available


  636. GALIMBERTI F, Li Y, Fernandez AP
    Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort.
    Br J Dermatol. 2016;174:158-64.
    PubMed     Text format     Abstract available


  637. STEELE RB, Nugent WH, Braswell SF, Frisch S, et al
    Pyoderma gangrenosum and pregnancy: an example of abnormal inflammation and challenging treatment.
    Br J Dermatol. 2016;174:77-87.
    PubMed     Text format     Abstract available


  638. ARNAUD A, Chosidow O, Detrez MA, Bitar D, et al
    Prevalences of scabies and pediculosis corporis among homeless people in the Paris region: results from two randomized cross-sectional surveys (HYTPEAC study).
    Br J Dermatol. 2016;174:104-12.
    PubMed     Text format     Abstract available


  639. YAN XX, Yu CP, Fu XA, Bao FF, et al
    CARD9 mutation linked to Corynespora cassiicola infection in a Chinese patient.
    Br J Dermatol. 2016;174:176-9.
    PubMed     Text format     Abstract available


  640. JOHN AM, Schwartz RA
    Basal cell naevus syndrome: an update on genetics and treatment.
    Br J Dermatol. 2016;174:68-76.
    PubMed     Text format     Abstract available


  641. AL-ISMAIL D, Edwards C, Anstey AV
    Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Br J Dermatol. 2016;174:131-5.
    PubMed     Text format     Abstract available


  642. LIN CH, Wei CC, Lin CL, Lin WC, et al
    Childhood type 1 diabetes may increase the risk of atopic dermatitis.
    Br J Dermatol. 2016;174:88-94.
    PubMed     Text format     Abstract available


  643. VAN GEEL MJ, Maatkamp M, Oostveen AM, de Jong EM, et al
    Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
    Br J Dermatol. 2016;174:152-7.
    PubMed     Text format     Abstract available


  644. KRYNITZ B, Olsson H, Lundh Rozell B, Lindelof B, et al
    Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.
    Br J Dermatol. 2016;174:95-103.
    PubMed     Text format     Abstract available


  645. MELLERIO JE, Robertson SJ, Bernardis C, Diem A, et al
    Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines.
    Br J Dermatol. 2016;174:56-67.
    PubMed     Text format     Abstract available


  646. POFF S, Li SC, Kelsey CE, Foeldvari I, et al
    Durometry as an outcome measure in juvenile localized scleroderma.
    Br J Dermatol. 2016;174:228-30.
    PubMed     Text format    


  647. HAGA N, Iwata H, Yamaguchi Y, Shirato T, et al
    Mucocutaneous pyoderma gangrenosum due to trisomy 8 neutrophilic infiltrates in a patient with myelodysplastic syndrome.
    Br J Dermatol. 2016;174:239-41.
    PubMed     Text format    


  648. KAMIYA K, Aoyama Y, Yamasaki O, Kamata A, et al
    Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
    Br J Dermatol. 2016;174:113-9.
    PubMed     Text format     Abstract available


  649. SCHNEIDER MR, Wolf E
    Genetically engineered pigs as investigative and translational models in dermatology.
    Br J Dermatol. 2016;174:237-9.
    PubMed     Text format    


  650. MANN J, Al-Niaimi F, Cooper A, Ghura V, et al
    A national survey of Mohs micrographic surgery in the U.K.
    Br J Dermatol. 2016;174:225-7.
    PubMed     Text format    


  651. MIZAWA M, Makino T, Nakano H, Sawamura D, et al
    Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Br J Dermatol. 2016;174:172-5.
    PubMed     Text format     Abstract available


  652. FAHMY J, Halabi-Tawil M, Ram-Wolff C, Bagot M, et al
    Paraneoplastic acanthosis nigricans: the first reported case associated with Sezary syndrome.
    Br J Dermatol. 2016;174:233-4.
    PubMed     Text format    


  653. COATES LC, Helliwell PS
    Psoriasis flare with corticosteroid use in psoriatic arthritis.
    Br J Dermatol. 2016;174:219-21.
    PubMed     Text format    


  654. CRALL C, Morley KW, Rabinowits G, Schmidt B, et al
    Merkel cell carcinoma in a patient with GATA2 deficiency: a novel association with primary immunodeficiency.
    Br J Dermatol. 2016;174:169-71.
    PubMed     Text format     Abstract available


  655. STOECKER WV, Rader RK, Rabinovitz HS, Oliviero M, et al
    Patient concern as a predictor of cutaneous malignancy.
    Br J Dermatol. 2016;174:222-4.
    PubMed     Text format    


  656. COTTLE DL, Kretzschmar K, Gollnick HP, Quist SR, et al
    p53 activity contributes to defective interfollicular epidermal differentiation in hyperproliferative murine skin.
    Br J Dermatol. 2016;174:204-8.
    PubMed     Text format    


  657. CHIRICOZZI A, Suarez-Farinas M, Fuentes-Duculan J, Cueto I, et al
    Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris.
    Br J Dermatol. 2016;174:136-45.
    PubMed     Text format     Abstract available


    December 2015
  658. UTER W
    Fragrance contact allergy in the population.
    Br J Dermatol. 2015;173:1358-9.
    PubMed     Text format    


    November 2015
  659. OFENLOCH R, Diepgen TL, Bruze M, Cazzaniga S, et al
    Colophony as marker for fragrance allergy in the general European population.
    Br J Dermatol. 2015 Nov 19. doi: 10.1111/bjd.14297.
    PubMed     Text format     Abstract available


    October 2015
  660. MECHINEAUD M, Nicaise D, Martin L
    Haemangioma in an infant whose mother was receiving long-term propranolol treatment during pregnancy.
    Br J Dermatol. 2015 Oct 19. doi: 10.1111/bjd.14235.
    PubMed     Text format     Abstract available


  661. RIBERO S, Zugna D, Osella-Abate S, Glass D, et al
    Prediction of high naevus count in a healthy UK population to estimate melanoma risk.
    Br J Dermatol. 2015 Oct 19. doi: 10.1111/bjd.14216.
    PubMed     Text format     Abstract available


    September 2015
  662. MOSER J, Moshammer R, Koglbauer G, Kitzwogerer M, et al
    Sentinel-node biopsy in melanoma: A single center experience with 216 consecutive patients.
    Br J Dermatol. 2015 Sep 24. doi: 10.1111/bjd.14189.
    PubMed     Text format     Abstract available


  663. ZARAGOZA J, Caille A, Beneton N, Bens G, et al
    Neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma.
    Br J Dermatol. 2015 Sep 6. doi: 10.1111/bjd.14155.
    PubMed     Text format     Abstract available


  664. DIEPGEN TL, Ofenloch R, Bruze M, Cazzaniga S, et al
    Prevalence of fragrance contact allergy in the general population of five European countries - a cross-sectional study.
    Br J Dermatol. 2015 Sep 2. doi: 10.1111/bjd.14151.
    PubMed     Text format     Abstract available


    August 2015
  665. GEBHARDT M, Ertas B, Falk TM, Blodorn-Schlicht N, et al
    Fast, sensitive, and specific diagnosis of infections with Leishmania species by Cytochrome b PCR in formalin-fixed, paraffin-embedded skin biopsies.
    Br J Dermatol. 2015 Aug 19. doi: 10.1111/bjd.14088.
    PubMed     Text format     Abstract available


    July 2015
  666. WU J, Lee YY, Su SC, Wu TS, et al
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in patients with malignancies.
    Br J Dermatol. 2015 Jul 27. doi: 10.1111/bjd.14052.
    PubMed     Text format     Abstract available


  667. BENATI E, Argenziano G, Kyrgidis A, Moscarella E, et al
    Melanoma and naevi with globular pattern: Confocal microscopy as an aid for diagnostic differentiation.
    Br J Dermatol. 2015 Jul 25. doi: 10.1111/bjd.14049.
    PubMed     Text format     Abstract available


  668. PICARD C, Gouarin S, Comoz F, Barreau M, et al
    Chronic active EBV infection with mainly cutaneous manifestation in a Caucasian woman with long-term follow-up.
    Br J Dermatol. 2015 Jul 4. doi: 10.1111/bjd.14014.
    PubMed     Text format     Abstract available


    June 2015
  669. POLANSKY M, Patel N, Feldman R
    Complete remission after rituximab therapy in an HIV positive patient with pemphigus vulgaris.
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13990.
    PubMed     Text format     Abstract available


  670. PIRMEZ R, Fernandes AL, Melo MG
    Photoaggravated contact dermatitis to Kathon CG (methylchloroisothiazolinone/methylisothiazolinone): a novel pattern of involvement in a growing epidemic?
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13986.
    PubMed     Text format     Abstract available


    May 2015
  671. BRUIJN MS, Horvath B, van Voorst Vader PC, Willemze R, et al
    Recommendations for treatment of Lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2015 May 22. doi: 10.1111/bjd.13920.
    PubMed     Text format     Abstract available


  672. POHLER E, Cunningham F, Sandilands A, Cole C, et al
    Novel autosomal dominant mutation in loricrin presenting as prominent ichthyosis.
    Br J Dermatol. 2015 May 12. doi: 10.1111/bjd.13895.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: